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INTRODUCTION 
Short history of total laryngectomy 
At the beginning of the nineteenth century, laryngology had not yet become a separate 
specialty. The most important laryngeal disorders were inflammatory diseases, such as 
diphtheria, croup and tuberculosis. Life expectancy was short and few people lived for 
long enough to develop malignant neoplasms of the larynx. If a laryngeal neoplasm did 
occur, it often went unrecognized. Several scientific advances led to increasing interest in 
the human larynx and to the first laryngectomy. 
Although it was not applied to medicine until the second half of the nineteenth century, 
the microscope, invented by Van Leeuwenhoek (1632-1723), a Dutchman, proved to be 
essential in the evolution of histology and histopathology. Around 1850, recognition of 
the possibility of tissue staining by Gehrlach, initially with natural dyes and later with 
artificial aniline, further stimulated the development of this specialty. Virchow was the 
first to study the histopathology of tumours accurately and he published his results in 
1858'. He is generally seen as the father of cellular pathology. 
The invention of the laryngeal mirror by Manuel Garcia, a Spanish singing teacher, in 
1854, enabled indirect examination of the larynx2. 
Other events that preceded the first laryngectomy were the production of inhalation 
anaesthetics and their application to humans around 1848 and the invention of an 
inflatable cuff tracheostomy tube by Trendelenburg in 18703. 
Watson has often been credited with performing the first laryngectomy on a human. The 
operation took place in 1866 on a patient for laryngeal syphilis. The credit seems to be 
undue, as the original paper describes only a tracheotomy and a postmortem demonstra-
tion of the larynx to the medico-surgical society of Edinburgh4. A few years later, in 
1870 Czerny5, an assistant of Billroth, experimentally laryngectomized five dogs and 
showed the feasibility of the operation. However, the fact that four of the dogs died after 
the procedure, restricted any progress with total laryngectomy. 
In 1874, Gussenbauer reported on the first laryngectomy carried out by Billroth (Figure 
1) in 1873 on a religious instructor who had recurrent laryngeal carcinoma6-7. 
The first laryngectomies were performed with great difficulties in making a preoperative 
diagnosis, both regarding the extent and the nature of the disease. 
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Figure 1: Theodore Billroth (1829-1894) (reprinted with permission from the Journal of 
Laryngology and Otology 1973; 87: 1162). 
It took until 1895 before Kirstein developed the laryngoscope for direct laryngoscopy. 
This enabled clinicians to study the macroscopic growth pattern of tumors and made it 
possible to obtain a biopsy of the tumor for histopathological classification. 
During the 1870s, Morel 1 Mackenzie put forward strong arguments in favour of taking 
biopsies from the larynx and proposed accurate tissue diagnosis as a conditio sine qua non 
for radical procedures such as total laryngectomy. However, the traumatic events related 
to the diagnosis of the laryngeal disease of Crown Prince Frederick of Germany resulted 
in a major dispute on the value of this diagnostic tool. Mackenzie was called to Germany 
in May 1887 to take a biopsy from Crown Prince Frederick who, on clinical grounds, 
was considered to be suffering from laryngeal carcinoma; he had been advised by German 
surgeons to undergo a laryngectomy. Specimens removed by indirect laryngoscopy were 
sent to the great pathologist Virchow on three separate occasions, but were reported 
negative. Mackenzie was therefore reluctant to advise surgery, despite the overwhelming 
clinical evidence that the lesion was malignant. It took until March 1888 before a positive 
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sputum diagnosis could be made by Waldeyer. By that time, a tracheostomy had been 
performed because of respiratory obstruction as the Crown Prince had refused laryngecto-
my. On 15 June 1888, Frederick III, who had been crowned Emperor a few months 
earlier, died of his metastasized malignant laryngeal tumour8. This event caused a set 
back of many years in the adoption of taking preoperative biopsies and the controversy on 
their value continued through the first quarter of the 20th Century, as many condemned 
laryngeal biopsy as being misleading and predisposing to the dissemination of cancer. 
In 1875, Enrico Bottini from Turin performed the first successful total laryngectomy on a 
patient who survived for 10 years after the operation9. Between 1870 and 1880, surgical 
mortality from total laryngectomy was around 50%. It was still difficult to make a 
preoperative diagnosis, there were no antibiotics and, as the pharynx was left open, 
aspiration pneumonia, generalized sepsis, neck infections and shock, were major 
problems. 
Unless a patient's life was extended by at least a year, total laryngectomy was not 
regarded to be successful, as it was believed that this length of survival could be achieved 
by tracheostomy alone. Only nine patients fulfilled this criterion in a review published in 
1887 on the first 103 total laryngectomies performed for cancer10. 
The introduction of an improved severed tracheostoma by Cohen in 1891 in addition to 
the application of the primary permanent repair of the pharynx, a surgical technique 
developed by Gluck in 1894, reduced the danger of aspiration pneumonia and neck 
infections, and improved survival". 
Differences in behaviour between intra- and extralaryngeal varieties of laryngeal carcino-
ma were being noted by clinicians such as Krishhaber as early as in 187912. In 1922, 
Thomson emphasized the need for and importance of proper classification of intra- and 
extralaryngeal carcinomas". He drew attention to the aggressiveness of the extralaryngeal 
variety and the subglottic extension of the intralaryngeal forms and recommended 
laryngectomy in specific cases, for instance with extension of the disease too far 
anteriorly, posteriorly or below the cricoid cartilage and with cordal fixation. The 
classification proposed by Thomson was used for many years and can be regarded as one 
of the first steps on the path leading to the TNM classification which is presently being 
used worldwide14. 
As the majority of early patients selected for laryngectomy were suffering from advanced 
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malignancies, recognition of the importance of dissecting the lymphatic tissue in the neck 
that contained metastatic disease, was crucial to survival. The pioneering work of Georg 
Washington Crile, an American surgeon, on this subject had a major influence and can be 
seen as the basis for the radical neck dissection of today15. However, it took a considera-
ble time before laryngectomy and radical neck dissection were combined. 
In the early fifties after many years of improving the surgical procedures, Martin and 
Ogura can be credited with finally standardizing the techniques for laryngectomy and neck 
dissection, that are still being used today16·17. 
Parallel to the surgical treatment of laryngeal cancer, runs the history of radiotherapy. In 
1895, Rontgen announced the discovery of X-rays18. Soon afterwards it was recognized 
that X-rays have a biological as well as a photographic effect. Voigt from Hamburg is 
said to have treated the first patient with a head and neck malignancy by means of X-rays 
in 189619. In 1898, Pierre and Marie Curie discovered radium, which was first used 
therapeutically in 190120. The mortality rates after total laryngectomy were still very high 
around 1900 (approximately 25%), which further stimulated the development of this 
newly-recognized treatment option. 
Voice rehabilitation after total laryngectomy 
It is interesting to realize that what was probably the first reported case of oesophageal 
speech (in 1841) as well as the first artificial larynx (developed by Czermak in 1859) 
preceded the first laryngectomy by many years21·22. 
Therefore it is perhaps not surprising that the first successfully laryngectomized patient in 
1873 was already rehabilitated with an artificial device for voice restoration (Figure 2)6. 
Made by the instrument maker Thürriegl, it consisted of a trachea cánula, a pharyngosto-
my cánula and a phonatory part with a musical reed for sound production. It seemed to 
perform very well, as Gussenbauer stated that the patient could be heard on the other side 
of a large hospital ward while reading. In the last few decades of the 19th century, 
numerous ingenious devices were described for recreating the voice23. Most of these 
devices were powered by the patients own breath, while some used bellows or even 
electricity24·25. After successful primary closure of the pharynx, the sound produced by the 
reeds incorporated into these instruments needed to be transported to the mouth or nose 
with external rubber tubes. 
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Figure 2: Schematic drawing of the artificial larynx used to rehabilitate the first 
laryngectomized patient, (reprinted with permission from the Journal of 
Laryngology and Otology 1975; 89: 357) 
The high mortality rate after total laryngectomy of approximately 25% around 1900 
stimulated the application of radiotherapy to laryngeal carcinoma. It is possibly as a result 
of this that essentially, no new artificial laryngés were mentioned in the literature between 
1900 and 1925. The further development of artificial laryngés has been described 
elsewhere23 and is, together with that of conventional oesophageal speech, beyond the 
scope of this thesis. 
At present, oesophageal speech is still in use and can play an important role in 
combination with the electrolarynx if surgical prosthetic voice restoration cannot be 
achieved for whatever reason. 
Surgical voice restoration 
The development of surgical voice restoration was initiated by a patient of Dr Beck who 
was successfully rehabilitated with a self-inflicted tracheo-hypopharyngeal fistula. 
Frustrated with his artificial larynx, he passed a red-hot ice-pick into his tracheostoma 
and up through his hypopharynx26. By occluding his tracheostoma, he was able to expire 
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air through the fistula towards his hypopharynx, where it created a voice. Inspired by 
this, Guttman developed a similar surgical procedure in which a fistula was created with a 
diathermic needle26·27. Spontaneous early closure of the fistula prohibited any long-term 
successful speech and the procedure was temporarily forgotten. 
In 1952, Briani described a surgical procedure to create a pharyngo-cutaneous fistula by 
means of an anterior neck flap28. Later, he simplified this into a puncture technique29. As 
was always the case with external shunts to the digestive tract, an external, often large 
and conspicuous device was needed to connect the tracheostoma with the pharyngocuta-
neous fistula. 
In an effort to prevent leakage or stenosis of the fistula, Conley described several 
techniques that used tubed oesophageal mucosa or autogenous vein grafts to create 
oesophago-cutaneous shunts. The superior end of the tube could either be connected to the 
skin superior to the tracheostoma or to the postero-superior tracheal wall, which avoided 
the need for an external device in the latter case30,31,32. Unfortunately, his aims to prevent 
leakage and stenosis could not be met. 
The same applied to Asai's three-stage method to create a tracheo-oesophageal 
shunt33,34,35. Despite numerous modifications36"39 and widespread support in the literature36" 
46
, the aspiration of mucous and ingested liquids or solids, as well as stenosis of the 
shunt, were major limitations of this procedure35·36·38·43·45. 
Another surgical procedure that has gained worldwide popularity, was introduced by 
Staffieri in 196947. In a single-stage procedure, a mucosa-lined slit-like fistula was created 
in the anterior pharyngo-oesophageal wall and sutured to the top of the tracheal stump. 
Due to its resemblance to the glottis, it was called the "Neoglottis Phonatoria"48. Like 
most of the previously described surgical procedures, the Staffieri procedure was 
successful in producing excellent phonation in the majority of cases49,50·51, but it failed to 
avoid severe chronic aspiration in a significant number52·53. 
The same problems were encountered with the one-stage procedure for surgical voice 
rehabilitation after laryngectomy, developed by Amatsu5455. He created a tracheal mucosal 
flap from the posterior tracheal wall and tunnelled this over a tracheo-oesophageal side-to-
side anastomosis. 
Surgical prosthetic voice restoration 
In order to overcome the problems associated with the above described unprotected 
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shunting techniques, attention was diverted to designing prosthetic devices that prevented 
stenosis and leakage. In 1972, Mozolewski was the first to describe an internal valve 
prosthesis for post-laryngectomy voice rehabilitation56. 
With the development of a commercially available silicone valve for use in a side-to-side 
tracheo-oesophageal anastomosis, Singer and Blom introduced a method that offered 
excellent tracheo-oesophageal speech, while eliminating the risk of surgical complications 
such as the aspiration of pharyngeal contents through leaking shunts and the spontaneous 
closure of shunts57. 
The world-wide interest in voice prosthesis assisted tracheo-oesophageal speech that 
resulted from this, led to the development of numerous other voice prostheses58"66. In 
many cases, the use of a particular device remained limited to certain centres. Only a few 
attracted longer-lasting world-wide interest. 
Over the past sixteen years, most of the leading devices have been redesigned. This has 
ultimately led to a select group of indwelling low-resistance voice prostheses that are 
widely used today67"69. 
Aim of the study 
The standard Groningen and Provox voice prostheses were introduced in 1982 and 1990, 
respectively58·61. They are being used world-wide for voice rehabilitation after total laryn-
gectomy. The standard Groningen voice prosthesis was redesigned in order to improve its 
aerodynamic characteristics; this resulted in the introduction of the low-resistance 
Groningen voice prosthesis around 199068. Recently, the ultra-low-resistance Groningen 
voice prosthesis has been introduced. The Nijdam voice prosthesis is a third Dutch design 
that became commercially available in 1989. 
This study was started to define the value and characteristics of the Nijdam voice 
prosthesis, to compare the Groningen, Nijdam and Provox voice prostheses and to 
evaluate the usefulness of tracheostoma valves. 
The Nijdam voice prosthesis has been in use at our department since its introduction and 
has been studied extensively since then. Chapter 2 of this thesis describes the Nijdam 
voice prosthesis with special reference to its innovative valveless design. Results obtained 
are described. 
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In order to compare the low-resistance Groningen, Nijdam and Provox voice prostheses, a 
prospective study was started in 1991. Chapter 3 describes the clinical aspects of these 
voice prostheses and a comparison is made based on 845 replacements. 
The progress in time and final success rates of speech and voice rehabilitation with the 
three different devices were investigated prospectively and the results are described in 
Chapter 4. 
In order to obtain effortless and fluent speech it is important for a voice prosthesis to 
have favourable aerodynamic characteristics. This has led to the development of low-
resistance devices. As the aerodynamic characteristics of the Nijdam voice prosthesis 
were unknown, we developed an in vitro model to obtain this information. The results of 
this study are described in Chapter 5. 
The valveless Nijdam voice prosthesis forms a barrier by means of close contact between 
its oesophageal flange and the oesophageal mucosa. A recent study70 has shown the 
importance of the pliability of the oesophageal mucosa. Due to radiation or prior surgery, 
the characteristics of the oesophageal mucosa of our patients may have differed from the 
porcine oesophageal tissue used in our in vitro model. It was therefore found necessary to 
investigate the in vivo aerodynamic characteristics of the Nijdam voice prosthesis. 
Chapter 6 describes a method that can be used to make this type of measurement and the 
results obtained. 
One of the disadvantages of voice prosthesis assisted tracheo-oesophageal speech is the 
need to occlude the tracheostoma manually during speech. To enable "handsfree" speech, 
tracheostoma valves have been developed. To define its usefulness, thirty patients were 
provided with a tracheostoma valve. Chapter 7 describes the experience of these patients. 
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ABSTRACT 
Voice prosthesis (VP) assisted speech rehabilitation after total laryngectomy has proven to 
be successful in the majority of patients and exceeds the results of traditional oesophageal 
speech. Nevertheless 10 to 30% failure rates are still reported. In part this is due to 
prosthesis-related problems, in particular ingrowth of Candida species in the valve bearing 
parts of the devices. A new indwelling, low-resistance and valveless voice prosthesis is 
described; the Nijdam voice prosthesis. The device has an average device lifetime of 19 
weeks which appears to be superior to other indwelling voice prostheses. Replacement 
indications mainly comprise leakage or increased airflow resistance. Most frequent local 
complications are granulation tissue and hypertrophic scar tissue formation. These occur 
in 12% of the patients and can easily be treated. Replacement is a simple outpatient 
procedure. The prosthesis is interchangeable with other types of indwelling voice 
prosthesis. 
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INTRODUCTION 
Although non-shunt oesophageal voice rehabilitation was the standard for laryngectomees 
for many years, this has gradually been changing over the past 15 years. Airway shunting 
to the digestive tract, initially with unprotected shunting techniques1·2 allowed fairly 
natural, fluent speech for the majority of patients. A major drawback was the occurrence 
of aspiration (of saliva, fluid and food substances) on the one hand and secondary stenosis 
on the other. 
The introduction of the one-way valved silicone prosthesis3 was a major step forward; it 
prevented aspiration as well as premature closure of the shunt. Over the past fifteen 
years, several (non-)self-retaining voice prostheses (VP) and low-pressure modifications 
have been developed for postlaryngectomy voice rehabilitation3"8. Almost all low-pressure 
devices presently available have a high voice rehabilitation success rate after total 
laryngectomy, which ranges from 60-90%9"". These different rates are only partly related 
to the device used. More often there will be a relationship with the extent and technique 
of surgery. Better results are achieved with primary placement than with secondary place-
ment12·13. The majority of patients benefit from pharyngeal plexus neurectomy or 
myotomy of the cricopharyngeal and lower pharyngeal muscles at primary operation1416. 
In addition, the experience and postoperative concern of both the surgeon and the speech 
therapist are likely to effect the final result, as well as patient related factors such as 
manual dexterity, intelligence, psychological and sociological factors1718. 
Vocal rehabilitation is one of the most important factors that defines the quality of life 
after total laryngectomy. Therefore, continuous efforts to improve rehabilitation of the 
lost voice after total laryngectomy is mandatory and should also be directed towards 
improving existing voice prostheses or developing new ones. Prosthesis-related factors 
such as aerodynamic properties, early material deterioration, dysfunction of the valve 
mechanism and a tendency to induce tissue reactions, should all be constantly reconside-
red for improvement. 
The ideal voice prosthesis, which should be biocompatible, self-cleaning, have a low-
resistance, be resistant to fungi, leakproof and suitable for primary placement with an 
unlimited device lifetime, does not exist yet. 
We have tried the newly developed, valveless Nijdam voice prosthesis extensively. It 
comes closer to the above-mentioned goals. Our experience is presented in this paper. 
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Development and description of the Nijdam Voice Prosthesis 
From long-term investigations on the Groningen VP, it has become obvious that the 
device lifetime is limited by the ingrowth of fungi in the oesophageal part of the prosthe-
sis22. This decreases the flexibility of the silicone elastomer and leads to increased rigidity 
of the material. Problems mainly occur in the valve-bearing part of the device and cause 
leakage through the prosthesis or increase the airflow resistance; both malfunctions 
indicate the end of the life of the device. Since 1984 efforts have been made to develop a 
valveless voice prosthesis. 
The Nijdam VP (Figure 1) is made of medical grade silicone elastomer. It consists of a 
biflanged hollow shaft of variable length and diameter. Two shaft diameters (standard 7 
mm and optional 8 mm) are available and there are five shaft lengths (4, 5, 6, 7 and 8 
mm) in order to enable proper adjustment to the size of the fistula and the variable 
thickness of the tracheo-oesophageal wall. The oval tracheal flange is equipped with a 
silicone string and a small perforation, both used for introduction (Figure 2). The length 
of the shaft of the prosthesis is printed on the tracheal flange. 
In this newly developed silicone voice prosthesis, the round oesophageal flange has open 
communication with the shaft of the prosthesis. 
Figure 1: The valveless Nijdam voice prosthesis. 
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Figure 2: The tracheal flange can be collapsed with the aid of the introduction string to 
promote easy passage of the prosthesis through the fistula. The size of the 
prosthesis is printed on the tracheal flange. 
The oesophageal flange covers the oesophageal end of the tracheo-oesophageal fistula like 
an umbrella. The rim of the oesophageal flange maintains slight pressure against the 
oesophageal mucosa and forms a barrier to prevent leakage. Thus the barrier mechanism 
is partially prosthetic and partially biological. As Candida decontamination does not 
influence the flexibility of the mucosa in the oesophagus, it was estimated that the 
ingrowth of the fungus in the material of the prosthesis would cause fewer problems with 
the occlusive mechanism. 
As voice production is initiated the stoma is occluded and the intratracheal pressure rises 
with attempted expiration. The oesophageal flange of the prosthesis is lifted off the 
oesophageal mucosa and air escapes into the oesophagus. This initiates vibrations of the 
pharyngo-oesophageal (PE) segment needed for speech (Figure 3). Proper adjustment of 
the length of the shaft to the thickness of the tracheo-oesophageal wall is mandatory, 
because a relatively long shaft may cause leakage, while a relatively short shaft may 
result in an increase in airflow resistance. It is our experience that proper adjustment is 
possible without the need for a measuring device. 
The Nijdam VP is interchangeable with other indwelling voice prostheses, such as the 
low-pressure Groningen VP, Blom-Singer VP (0 20 French) and the Provox VP. 
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Figure 3: The barrier mechanism of the Nijdam voice prosthesis. Artist's representation of 
the in vivo situation. The arrow indicates the airflow during speech that lifls the 
oesophageal flange (prosthetic part of the valve) away from the slightly 
depressed oesophageal mucosa (biological part of the valve). 
Surgical technique 
The surgical technique for primary as well as secondary placement is similar to that of the 
low-pressure Groningen VP and Provox VP, which has been described elsewhere19-20. 
Replacement procedure 
At the end of device lifetime, replacement is most frequently indicated by either leakage 
or increased airflow resistance. Replacement is normally an outpatient procedure. If 
desired, the trachea and oropharynx can be anaesthetized with 10% lidocaine spray. The 
Nijdam VP is very flexible and it can therefore easily be removed by pulling it out of the 
fistula with a haemostat (Figure 4). A flexible metal guide wire is introduced through the 
fistula into the oesophagus and pushed upwards towards the oropharynx and brought out 
through the mouth. The silicone introduction string of the Nijdam VP is fed through the 
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Figure 4: The flexibility of the Nijdam voice prosthesis enables transtracheal removal 
without the danger of damaging the fistula. 
perforation in the tracheal flange and pulled slightly which helps to streamline the 
prosthesis for easy introduction (Figure 2). 
Subsequently the introduction string is connected to the guide wire. The voice prosthesis 
is swallowed by the patient and pulled into place with the guide wire. The introduction 
string is cut off and the tracheal flange unfolds. The voice prosthesis is ready for use. 
MATERIAL AND METHODS 
From 1981 all the patients who underwent laryngectomy at the University Hospital 
Nijmegen were rehabilitated with a primary-placed indwelling voice prosthesis, unless this 
was contraindicated. Initially the standard Groningen VP was used at our clinic. Later, 
this device was replaced by a modification, the low-pressure Groningen VP, in which the 
valve mechanism was altered from a straight into a semicircular slit, thus reducing the 
airflow resistance by 50%7. In 1990, in addition to the low-pressure Groningen VP, the 
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Nijdam VP and Provox VP were introduced and adapted at our clinic. 
All prosthesis replacement procedures performed at our outpatient clinic between January 
1991 and July 1993 were evaluated prospectively. During the study period, 220 Nijdam 
VP's were replaced in 74 évaluable patients. After every replacement, a standard form 
was completed stating replacement indication, device lifetime, size of the old and new 
prosthesis, complications of the replacement procedure and the local appearance of the 
fistula. 
Seven laryngectomees who were using the Nijdam prosthesis, were selected at random for 
intra-tracheal pressure measurements. The mean device lifetime of the Nijdam prosthesis 
at the time of measurement was 35 days (range 17-48 days). The laryngectomees were 
asked to produce a sustained vowel /a/ at varying sound pressure levels, ranging from 
very soft to very loud. The intratracheal pressure with its corresponding sound pressure 
level were measured at a mouth-microphone distance of 30 cm. The pressure sensing 
catheter used to measure the intratracheal pressure was sealed by the patient between the 
tracheostoma and an occluding finger while producing a sustained /a/. The catheter was 
connected to a self-designed pressure transducer. The sound level was measured using a 
sound level meter (Briiel & Kjzer, type 2225). From these measurements the intratracheal 
pressure at a sound pressure level of 70 dB was calculated by interpolation. A sound 
pressure level of 70 dB at 30 cm mouth-microphone distance is equal to 67 dB at 50 cm 
distance, which is the mean intensity of the comfortable loudness of tracheo-oesophageal 
shunt speech. 
RESULTS 
No complications were encountered with the primary tracheo-oesophageal puncture and 
placement of the Nijdam VP. 
The average device lifetime of the Nijdam VP, based on 220 replacements was 19 weeks 
(standard deviation 21.7 weeks, range 1-156 weeks). The most frequent replacement 
indication was leakage through the voice prosthesis (50%); leakage around the voice 
prosthesis occurred in only 5% of replacements. Increased airflow resistance was the 
replacement indication in 45% of the replacements. The aspect of the fistula was normal 
in the majority of patients. Minor local complications consisted of granulation tissue 
(12%) and hypertrophic scar tissue formation (10%) which could be treated easily with 
cauterisation or local resection. Sometimes, a longer VP was inserted to avoid this local 
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problem, but it never resulted in permanent removal of the prosthesis. 
Complicated removal was often associated with granulation tissue or hypertrophic scar 
tissue formation. Sometimes, a narrow tracheostoma also caused problems. Loss of the 
prosthesis and removal under general anaesthesia were classified under the complicated 
removals. Complicated insertion was often related to hypopharyngeal or oesophageal 
stenosis. To find the tract, sometimes retrograde insertion of a nasogastric tube was 
necessary as a first step to replace a prosthesis. Retrograde insertion was included among 
the complicated insertions. In some cases the introduction string broke during insertion or 
insertion had to be carried out under general anaesthesia. Complicated removal occurred 
in 3.6% and complicated insertion in 11.5% of replacements. Replacement complications 
were mostly of a minor nature. Replacement under general anaesthesia was necessary in 
2.3% of our patients, all due to hypopharyngeal or tracheostoma stenosis. 
The intratracheal pressure of a sustained /a/ of 70 dB at a distance of 30 cm from the 
mouth was found to be 4.3 kPa (range 2.8-6.1 kPa). 
Subjectively the speech rehabilitation success rates with the Nijdam VP were comparable 
with those of the Groningen VP10. 
DISCUSSION 
The development of the low-resistance, valveless Nijdam VP has brought us some steps 
closer to an ideal VP. The innovative design of this flexible device, that can be stream­
lined for easy introduction, with a completely new barrier mechanism, more resistant to 
candida induced malfunctioning, means an improvement of existing voice prostheses. 
The average device lifetime of the Nijdam VP (л=220) of 19 weeks is significantly 
longer than the 15.8 weeks that we found for the Groningen VP (л=453) or the 13 weeks 
of the Provox VP (л=172). In our opinion, this is related to the valveless design of the 
Nijdam VP, with a barrier mechanism that is less sensitive to Candida-induced 
malfunctioning. Deterioration caused by Candida species is the most important factor for 
reducing device lifetime22. 
The valveless Nijdam VP is an indwelling device. Indwelling devices require little patient 
care. This seems to be an advantage, as complications have been reported in association 
with removal, cleaning and reinsertion of non-indwelling devices by the patient. 
Complications of the primary tracheo-oesophageal puncture were not encountered with the 
Nijdam VP. Replacement of the Nijdam VP is a simple outpatient procedure because it is 
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very flexible. It can therefore be removed easily by carefully pulling it out. Removal of 
other more rigid voice prostheses in this way should be avoided because it may traumatize 
the fistula, cause shunt insufficiency and subsequent periprosthetic leakage. Transoral 
removal of these devices, as well as reinsertion, can cause problems in patients with 
hypopharyngeal or oesophageal stenosis. This is reflected by the relatively high complica-
tion rate reported in the literature of 8% in patients using a Provox VP5, who needed 
dilatation under general or local anaesthesia before replacement. Even in patients with 
moderate hypopharyngeal or oesophageal stenosis, insertion of the flexible, streamlined 
Nijdam VP did not cause any problems. With transtracheal-transoral replacement, the 
oesophageal flange is always intra-oesophageally. There is no need for repeated X-ray 
examinations to check the proper positioning of the oesophageal flange, as is recommen-
ded for the new Blom-Singer VP with transtracheal gel-cap insertion21. Anterior dislodge-
ment and aspiration of a Nijdam VP have not been observed in our series. 
The "umbrella effect" of the Nijdam VP, in which the oesophageal flange protects the 
oesophageal end of the fistula from leakage around the prosthesis, may explain why 
leakage around the prosthesis as a replacement indication only occurred in 5% of the 
Nijdam VP replacements. This compares favourably with the reported 20.5% of Provox 
users who need some sort of treatment because of widening of the fistula and leakage 
around the voice prosthesis11. Occasionally, a Nijdam VP can be used to replace a 
Groningen VP or a Provox VP if there is leakage around the device and temporary 
removal with reinsertion of the prosthesis after shrinkage of the fistula is considered to be 
too long-winded. Gax-collagen injection as a treatment option to correct an enlarged 
fistula is said to have good results as well23, although the advised tolerance test does seem 
to interfere with the acute nature of leakage around a voice prosthesis. 
Although the intratracheal pressure during voice-prosthesis-assisted tracheo-oesophageal 
speech is only partly caused by the prosthesis itself, it is a strong indicator of the 
aerodynamic characteristics of a device. We compared the intratracheal pressure of the 
Nijdam VP to that reported for other shunt valves. 
During comfortable speech, the mean intratracheal pressure of the standard Groningen 
VP24, the low-resistance Groningen VP25 and the Provox VP5 were 9.3 kPa (4.0-16.2 
kPa), 3.3 kPa (P25 = 2.4 kPa and P„s = 4.6 kPa) and 1.9 kPa (1.0- 3.8 kPa), 
respectively. The airflow-resistance of the Blom-Singer low-pressure VP is comparable 
with that of the low-resistance Groningen VP7. 
The mean intratracheal pressure of the Nijdam VP was 4.3 kPa (2.8-6.1). This is 
significantly lower than that of the standard Groningen VP, but the latter is not conside-
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red to be a low-resistance VP and should therefore be avoided. When interpreting these 
data, it should be realized that our measurements were not done immediately after the 
insertion of a new Nijdam VP but after the voice prosthesis had been in situ for an 
average of 35 days. It has been reported that the intratracheal pressure of the low-
resistance Groningen VP increases from 3.3 kPa (P25 = 2.4 kPa and P975 = 4.6 kPa) to 
4.7 kPa (P25 = 2.6 kPa and P975 = 8.5 kPa) after three to four months of use25. 
The aerodynamic characteristics of the Nijdam VP are comparable with those of the low-
resistance Groningen VP so it can be considered to be a low-resistance device. 
The valveless Nijdam voice prosthesis has advantages over the existing devices: a longer 
device lifetime, simple replacement procedure, less sensitivity to Candida-induced 
malfunctioning and infrequent peri-prosthetic leakage caused by enlarged fistulas. The 
main disadvantage is the need for some amount of experience with adjusting the shaft-
length of the prosthesis so that it conforms with the thickness of the tracheo-oesophageal 
wall. 
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ABSTRACT 
The Groningen, Nijdam and Provox voice prostheses (VP) are all low-pressure, indwel-
ling voice prostheses. Although there are differences concerning the valve mechanism, 
they have a similar design and are therefore interchangeable. In a prospective study, 845 
consecutive replacements were evaluated in 158 patients. Average device lifetime differed 
significantly from 13 weeks for the Provox VP and 15.8 weeks for the Groningen VP, to 
19 weeks for the Nijdam device. Leakage through or around a voice prosthesis was the 
main replacement indication. Leakage occurred significantly more often with the Provox 
VP (80.2%) than with the Groningen VP (58.8%) or the Nijdam VP (55%). Increased 
airflow resistance as a replacement indication occurred significantly more often with the 
Groningen VP (45.4%) and the Nijdam VP (45.9%) than with the Provox VP (22.7%). 
Complications during the replacement procedure were rare and usually mild. Replacement 
was usually an easy outpatient procedure; general anaesthesia was only necessary in 3.0% 
of 845 replacements, without any significant difference between the three devices. Granu-
lation tissue and hypertrophic scar tissue formation were the most frequent local compli-
cations. They occurred in less than 10% of our patients but were significantly more 
common in patients with a Nijdam VP. 
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INTRODUCTION 
Since Billroth performed the first laryngectomy in 1873, much has changed in relation to 
both the surgical technique and postoperative voice restoration. At present, there are three 
ways of rehabilitating the lost voice of laryngectomy patients. Mechanical sound sources, 
such as the pneumolarynx and electrolarynx were developed in the late 19th century. 
They produce voice sounds either by air or electrically induced vibrations but are 
considered inferior to the other forms of voice restoration. In the same period, oesopha-
geal voice production was recognised as a useful means of voice production after total 
laryngectomy. The voice rehabilitation process was improved further with the introduction 
of surgically created tracheo-oesophageal shunts1,2. A major step forward was the 
application of the tracheo-oesophageal puncture with insertion of a silicone voice pros-
thesis by Blom and Singer3 in 1979. This also made it possible to deal with shunt stenosis 
and aspiration which were major complications of the previously unprotected tracheo-
oesophageal shunts. Prosthesis-assisted tracheo-oesophageal speech is now generally 
considered to be superior to any other form of substitute voice production4·56. 
Voice prostheses have been developed in various countries all over the world, including 
three in the Netherlands: the Groningen voice prosthesis (VP), the Nijdam VP and the 
Provox VP. The Provox VP7 and the Groningen VP8 are used worldwide and can be 
considered popular, together with the Blom-Singer VP10. The Nijdam VP9" is a valveless 
design which can have specific advantages in selected patients. The Groningen, Nijdam 
and Provox voice prostheses are interchangeable. They were compared in a prospective 
analysis. 
Description of the devices 
The standard Groningen VP was designed by the Department of Otorhinolaryngology of 
the University Hospital Groningen and introduced for use in 1981s. It consists of a 
tracheal and oesophageal flange and a shaft of variable length (5-13 mm). This makes it 
possible to adjust the device to the thickness of the tracheo-oesophageal wall. The 
Groningen VP has a standard 7 mm or an optional 8 mm shaft diameter. There was a 
straight slit centrally through the oesophageal flange of the initial device which acted as a 
valve (Figure la). In 1988 this slit was made semicircular, which reduced the airflow 
resistance by 50% (Figure 1¿>)12. 
The Provox VP has a hinge-type valve and was introduced in 1990 (7)(Figure lc). It has 
a tracheal and oesophageal flange and is available in three shaft lengths (6, 8 and 10 
mm). The Provox VP has an outer shaft diameter of 7.5 mm. In 1990 the valveless 
Nijdam VP was also introduced (Figure Id). It has a completely new innovative barrier 
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Figure 1: The standard Groningen VP with a straight slit-valve (a), the low-resistance 
Groningen VP with a semicircular slit-valve (b), the Provox VP with a hinge-
valve (c). The valveless Nijdam VP (d) with the shafllength of the VP (mm) 
printed on the tracheal flange. The barrier mechanism of the Nijdam VP (e); 
the hatched area represents the tracheo-oesophageal wall. 
mechanism. At the initiation of voice production, the oesophageal flange of the prosthesis 
is lifted off the oesophageal mucosa and air escapes into the oesophagus which produces 
the vibrations of the PE segment needed for speech (Figure le). It also has a tracheal and 
oesophageal flange and a shaft of variable length (4, 5, 6, 7 and 8 mm). The Nijdam VP 
is available with a standard 7 mm or an optional 8 mm shaft diameter. 
Replacement 
Replacement is generally a simple outpatient procedure and differs slightly for the three 
devices (Figure 2). The trachea and oropharynx are anaesthetized locally, if desired, with 
10% lidocaine spray and/or lidocaine oral gel 20 mg/ml to reduce reflexes and minimize 
discomfort for the patient. The Groningen VP and Nijdam VP can be removed by pulling 
carefully with a haemostat (Figure la). After the Groningen or Nijdam VP have been 
removed, a flexible metal guide wire, which can be resterilized, is introduced through the 
fistula towards the oral cavity (Figure 2b). 
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Figure 2: The transtracheal-transoral replacement procedure (a-b-c-d-e; see text). 
Removal of a Provox VP (f-g-h; see text). 
The introduction string of a new prosthesis is connected to the guide wire (Figure 2c), the 
prosthesis is swallowed by the patient and pulled into place. Delivery of the tracheal 
flange is facilitated by the Nijdam design, but positioning can be adjusted using forceps in 
the Groningen VP. The introduction string is subsequently cut off (Figure 2d) and the 
new device is ready for use (Figure 2e). 
Removal of the Provox VP by pulling it out is potentially damaging for the fistula 
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because of its greater stiffness and should therefore be avoided. It can be removed by 
introducing a disposable guide wire through the shaft (Figure If). The tracheal flange is 
cut off (Figure 2g) and the oesophageal remnant of the prosthesis is removed transorally 
by a push-and-pull action of the guide wire which has a stop located halfway (Figure 2Λ). 
The insertion procedure of a new Provox VP is similar to the method described above 
(Figure 2c, d and e). 
Brushes for daily in situ maintenance have been developed for all three prostheses; plugs 
are available for temporary occlusion of an intermittently leaking prosthesis. 
All three prostheses are made of medical-grade silicone rubber and are considered to be 
indwelling, low-resistance voice prostheses. 
The Provox VP is produced and marketed worldwide by Atos Medical AB, P.O. Box 
183, S-242 22 Hörby, Sweden and is distributed in the Netherlands by Mediprof Holland 
BV, P.O. Box 138, 2665 ZJ Bleiswijk, the Netherlands. 
The Groningen VP and Nijdam VP are distributed by Medin ENT Instruments, P.O. Box 
6201, 9702 HE Groningen, the Netherlands. 
MATERIAL AND METHODS 
Since January 1991 a voice prosthesis (a Groningen, Nijdam or Provox VP) was chosen 
at random for placement during total laryngectomy. 
We evaluated all the replacement procedures which were conducted between January 1991 
and July 1993. A total of 158 patients participated in this study. They had a laryngectomy 
between February 1981 and February 1993. 
Replacement indications were leakage of the device which was objectivated at the 
outpatient clinic to differentiate leakage through the prosthesis from leakage around it. In 
the former case, prosthesis replacement was indicated. In the latter, temporary removal of 
the voice prosthesis was expected to result in shrinkage of the fistula in the majority of 
patients so that a new prosthesis could be inserted after a few days. Another indication for 
replacement of the voice prosthesis was a subjective feeling of increased airflow resistan-
ce during speech. There were other less frequent indications for replacement of the voice 
prosthesis, such as excessive granulation tissue formation or loss of the voice prosthesis. 
At the end of device life a voice prosthesis was normally replaced by a new voice 
prosthesis of the same type. Due to the experience gained during this study it became 
unavoidable to change to another type of voice prosthesis in some cases. A high airflow г 
esistance during speech could favour changing to a Provox VP, frequent leakage to a 
Groningen VP or Nijdam VP and periprosthetic leakage to a Nijdam VP. Replacement 
38 
The Groningen, Nijdam and Provox voice prostheses 
problems due to hypopharyngeal and/or oesophageal stenosis were sometimes avoided by 
changing to a Nijdam VP. In some cases the type of voice prosthesis was changed without 
a clear reason. 
Every time a VP was replaced, a standardised form was completed stating device lifetime, 
type and size of the VP being removed as well as of the one being inserted, complications 
associated with removal and/or insertion, indication for replacement and local appearance 
of the fistula. None of the patients used a cánula or other device to treat tracheostoma 
stenosis. During this period, 845 consecutive replacement procedures were performed in 
158 patients. 
RESULTS 
In the 845 replacement procedures, 453 Groningen VP were used, 172 Provox VP and 
220 Nijdam VP. Before 1990, all our laryngectomy patients were fitted with a Groningen 
VP because the other two were not yet available. This accounts for the difference in 
replacement numbers. The number of replacements per patient during study period ranged 
from 1 to 35 (Figure 3). 
In 80% to 90% of the replacements, the shaft length remained the same indicating no 
change in the thickness of the tracheo-oesophageal wall (Figure 4). In 75%-91% of the 
replacements, the prosthesis was replaced by a device of the same type (Table 1). 
The Nijdam VP was replaced significantly more often by a Groningen VP or a Provox 
VP which indicated that there were prosthesis-related problems, and a different device 
was expected to be a possible solution. 
Patients 
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Figure 3: The total number of replaced voice prostheses per patient. 
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Nijdam (n-165) GVP (n=412) Provox (n=145) 
D shorter Ξ same shaftlength M longer 
Figure 4: Adjustment of shaft length during replacement (GVP = Groningen voice 
prosthesis). 
Table 1: Replacement by the same or another device 
(out) (in) Nijdam Groningen Provox 
Nijdam 75.4% 16.4% 8.2% 219 
Groningen 4.4% 90.9% 4.7% 451 
Provox 3.5% 10.7% 85.8% 169 
total 839 
The Nijdam VP needed to be replaced after an average of 19 weeks. This was signifi­
cantly longer than the average lifetime of the Groningen VP of 15.8 weeks (p < 0.04) 
and longer than the average lifetime of 13 weeks of the Provox VP (ρ < 0.004) (Figure 
5). 
In general, the main replacement indications were increased airflow resistance, often due 
to deterioration of the prosthesis by Candida albicans, and leakage either through the 
prosthesis or around it if the fistula had become too wide. 
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Figure 5: Average device lifetime of the three voice prostheses (GVP = Groningen voice 
prosthesis). 
Percentages 
Airflow Resistance Leakage Other 
Replacement indication 
Π Nijdam (n-220) В GVP (n=453) Ш Provox (n«172) 
Figure 6: Replacement indications for the three devices (GVP = Groningen voice 
prosthesis). 
In our patients, leakage was the main reason for replacement of the prosthesis (Figure 6); 
leakage occurred much more often through the VP (80-90%) than around it (10%). It was 
necessary to replace 80.2% of the Provox VP's because of leakage. This percentage was 
significantly higher than the percentages for the Groningen VP and the Nijdam VP for 
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this indication: 58.8% and 55%, respectively (p < 10.-6). 
Increased airflow resistance was the reason to replace 22.7% of the Pro vox VP's. For the 
Nijdam VP and the Groningen VP these percentages were significantly higher: 45.9% and 
45.4%, respectively (p < 10.-6) (Figure 6). 
During replacement there was no evidence of any local problems with the Nijdam VP, 
Provox VP or Groningen VP in 73%, 79% and 82% of the users, respectively. The most 
frequent local complications were formation of granulation tissue and hypertrophic scar 
tissue (Table 2). These complications occurred significantly more often in combination 
with the Nijdam VP than with the Groningen VP (ρ < 0.01). 
Replacement was a quick and easy outpatient clinic procedure and complications were 
usually mild and rare. Complicated removal was often associated with granulation tissue 
or hypertrophic scar tissue formation. 
Table 2: Local appearance of the fistula at replacement 
Nijdam Groningen Provox 
Normal 
Granulation 
Hypertrophia 
Infection 
Other/not stated 
73% 
12% 
10% 
0% 
15% 
82% 
6% 
4% 
0% 
16% 
79% 
6% 
4% 
2% 
17% 
Occasionally, a narrow stoma was also a problem. Loss of the prosthesis and removal 
under general anaesthesia were counted under complicated removals. Complicated 
insertion was often related to hypopharyngeal or oesophageal stenosis. To find the tract, 
sometimes retrograde insertion of a nasogastric tube was necessary as a first step to 
replace a prosthesis. Retrograde insertion was included among the complicated insertions. 
Also breakage of the introduction string occurred during insertion and in some cases 
insertion was necessary under general anaesthesia. Complicated removal was reported in 
3.6% of the patients with a Nijdam VP, in 2.9% with a Groningen VP and in 6.0% with 
a Provox VP. These differences were not significant. Complicated insertion was recorded 
in 11.5% of the patients with a Nijdam VP, in 9.4% with a Groningen VP and in 18.5% 
with a Provox VP. The latter percentage was significantly higher (p < 8.8 χ 10.-6). 
3.0% of the replacements were done under general anaesthesia. There was no significant 
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difference between the three devices. Replacement under general anaesthesia occurred in 
4.0% of the Provox VP replacements, 2.3% of the Nijdam VP replacements and 2.7% of 
the Groningen VP replacements. 
DISCUSSION 
The Groningen, Nijdam and Provox VP's are all low-resistance, indwelling voice prosthe-
ses. Average device lifetime differed from 13 to 19 weeks. It may be possible to prolong 
the lifetime by the proper use of the brushes and plugs in cases of unexpected or tempora-
ry leakage. The devices are interchangeable and replacement is an easy outpatient clinic 
procedure. Replacement complications were rare and usually mild, which made replace-
ment under general anaesthesia necessary in only 3.0% of the 845 replacements. Granula-
tion tissue and hypertrophic scar tissue formation were the most frequent local 
complications. They occurred in less than 10% of our patients. 
This study revealed that the Nijdam VP was replaced significantly more often by a 
Groningen VP or a Provox VP than vice versa. This seemed to be related to the barrier 
mechanism of the Nijdam VP. The Nijdam VP is a valveless prosthesis. To prevent 
leakage, close contact is necessary between the oesophageal flange of the Nijdam VP and 
the mucosa of the oesophagus, which is reflected in the length of the shaft. If the shaft is 
too short, it may result in an increase in airflow resistance and granulation tissue forma-
tion. If the shaft is too long, it can cause early leakage through the prosthesis. Both 
complications can be prevented by choosing a correct shaft length for the Nijdam VP. We 
think that in our patients such complications often led to an unnecessary change to a 
Provox VP or Groningen VP. 
The significantly longer lifetime of the Nijdam VP seemed to be related to the absence of 
a valve. Deterioration of the valve of the Groningen VP and the Provox VP, usually due 
to Candida albicans ingrowth, was the main cause of reduced lifetime. 
Another possible advantage of the oesophageal flange of the Nijdam VP is its "umbrella 
effect". Even if the tracheo-oesophageal fistula is a little too wide, the oesophageal flange 
will cover it as an umbrella and prevent leakage around the shaft of the prosthesis. Other 
options in this event would be temporary removal of the voice prosthesis with reinsertion 
after a few days when the fistula has shrunk. Also Gax-collagen injection has been 
mentioned as a solution to correct an enlarged tracheo-oesophageal fistula13. 
The stiffness of the Provox VP, which is enhanced by the valve mechanism in the shaft, 
causes difficulties during replacement, particularly under less favourable conditions, such 
as hypopharyngeal stenosis. In these cases, the Nijdam VP is easier to replace because of 
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its flexibility and special design of the tracheal flange. 
A major advantage of the Provox VP is the fact that it has dramatically diminished the 
number of patients with increased airflow resistance as a replacement indication. If there 
is a recurrent early increase in airway resistance, changing the patient to a Provox VP 
should be considered. 
If a patient with a VP wishes to travel (abroad), they can regain part of their independen-
ce by carrying a complete Provox replacement set, even if they are normally using 
another device because the devices are interchangeable. The complete set, including an in-
struction manual, makes it possible for any experienced otorhinolaryngologist to replace 
the device if necessary. 
Financial costs may form an important reason for choosing the cheaper Groningen VP or 
Nijdam VP in favour of the more expensive Provox VP. 
The present study indicates that the Nijdam VP has advantages over the Groningen VP 
and Provox VP, especially with regard to its lifetime. Choosing the correct length of the 
Nijdam VP is very important. 
The interchangeability of the devices is a great advantage. Specific prosthesis-related 
problems in individual patients can very often be solved by knowing and making use of 
the mentioned differences between the three Dutch voice prostheses. We have found that 
simultaneously using the Groningen, Nijdam and Provox VP's has definitely contributed 
to successful voice rehabilitation in our laryngectomy patients. 
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ABSTRACT 
In a prospective study the Groningen, Nijdam, and Provox voice prostheses (VP's) were 
evaluated as to their success rate with respect to speech and voice rehabilitation. At 1, 4, 
and 10 months post-operatively, patients were submitted to a standardized speaking task 
to evaluate phonatory skills ('utterance size', 'phonation duration', 'dynamics on tone', 
'dynamics on sentence', 'speech rate' and 'availability of sound'), speech quality 
('fluency' and 'overall intelligibility'), voice quality and stoma technique ('stoma noise'). 
Tracheo-oesophageal speech rehabilitation proved to be successful in 94%-100% of our 
patients, as measured at 10 months post-operatively. 
Furthermore, no significant overall differences were found between the three VP's 
evaluated. We did observe a significant improvement in time for speech rate and stoma 
noise, and a positive tendency for fluency and overall intelligibility, as well as for overall 
performance. With regard to these time effects no differences between the three VP's 
were found. 
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INTRODUCTION 
Singer and Blom's description' of their tracheo-oesophageal puncture technique with 
insertion of a silicone voice prosthesis (VP) started off a new era of post-laryngectomy 
voice rehabilitation. Sixteen years later prosthesis-assisted tracheo-oesophageal speech is a 
generally accepted form of substitute voice production. In these years numerous voice 
prostheses have been developed. Most of the second generation VP's are indwelling 
devices with improved aerodynamic characteristics, lowering the resistance of the 
prostheses. The voice prostheses that have been developed in the Netherlands meet 
present day demands: the Groningen VP2, the Nijdam VP3 and the Provox VP4. 
All three VP's are in use for voice rehabilitation after total laryngectomy at the University 
Hospital of Nijmegen, the Netherlands. In 1991 a prospective study was started to 
evaluate the voice and speech rehabilitation process with these three VP's, with special 
attention to the possible effect of the different designs and of the different aerodynamic 
characteristics5·6·7. 
To this end, the patients' performances with respect to phonatory skills, speech quality, 
voice quality, and stoma technique were evaluated at regular intervals. 
The Groningen, Nijdam and Provox VP's are low-resistance indwelling devices made of 
medical grade silicone rubber. The main difference between the three is their valve 
mechanism. 
The low-resistance Groningen VP has a semi-circular slit valve, the Provox VP has a 
hinge valve in the shaft of the VP, and the Nijdam VP has a valveless design, i.e. the 
oesophageal flange of this prosthesis forms a barrier in combination with the oesophageal 
mucosa (Figure 1). 
In 1981 the the standard Groningen voice prosthesis was introduced2. It is a bi-flanged 
shaft of variable length (5-13 mm) so that the device can be adjusted to the thickness of 
the tracheo-oesophageal wall. The shaft has a standard 7 mm or an optional 8 mm 
diameter. The oesophageal flange of the initial device has a centrally placed straight slit 
which acts as a valve. In 1988 the airflow resistance was reduced with 50% by making 
this slit semi-circular (Figure la)5. 
The Provox VP was introduced in 19904; it has a hinge-type valve (Figure lb) applied 
inside a biflanged shaft and it is available in four shaft lengths (4.5, 6, 8 and 10 mm). 
The outer shaft diameter is 7.5 mm. 
The valveless Nijdam VP3 was also introduced in 1990 (Figure lc). It has an innovative 
barrier mechanism. The oesophageal flange of the prosthesis is lifted off the oesophageal 
mucosa at the initiation of voice production, and air escapes into the oesophagus where it 
produces vibrations of the pharyngo-oesophageal segment (PE segment) needed for speech 
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Figure 1: The low-resistance Groningen VP (a), Provox VP (b), and Nijdam VP (с), and 
the barrier mechanism of the Nijdam VP (d). The tracheo-oesophageal wall is 
represented by the hatched area. 
(Figure id). It is also bi-flanged with a shaft of variable length (4-8 mm) and a variable 
outer shaft diameter of 7 or 8 mm. 
The main research questions of the present study are: 
1. Does the type of VP affect performance? I.e. is performance with one type of VP 
significantly better (or worse) than performance with the other two types? 
Are there any particular skills that are more sensitive to the type of VP than other 
skills? E.g. does a VP with a lower resistance give rise to a better performance with 
respect to phonatory skills? 
2. Does performance improve over time? In other words, is there an overall effect of 
time to be attributed to the patient's increased experience with the VP? 
3. Does the type of VP affect the rate of improvement over time? Is there a difference 
in improvement for the three types of VP tested? 
50 
A prospective study of speech and voice 
METHOD 
Patients 
From April 1991 until July 1994 113 patients underwent a total laryngectomy mostly for 
squamous cell carcinoma of the larynx, at the University Hospital of Nijmegen, the 
Netherlands. 
In 8 patients (7.1%) it was decided not to place a VP at the time of total laryngectomy 
(primary placement), the main reason being the extension of the primary tumor: 6 patients 
needed extensive tracheal resection because of subglottic extension (secondary placement 
was planned after tumor resection margins were reported free of tumor at routine 
histopathological evaluation), 1 patient needed resection of the base of the tongue, and in 
1 patient there was an obvious irradical resection making it a palliative treatment. 
So there were 105 patients potentially to be included in our study. During total 
laryngectomy they received a low-resistance Groningen, Nijdam or Provox VP (primary 
placement). 
The type of VP to be placed (and thus the assignment of the patient to one of the three 
VP groups) was determined at random during the operation by means of throwing a 
sterilized dice. This randomisation resulted in 32 patients (30.5%) receiving a Groningen 
VP, 33 patients (31.4%) a Nijdam VP, and 40 patients (38.1%) a Provox VP. 
Of these 105 patients 40 had to be excluded from our study for various reasons beyond 
our control. These reasons and the number of patients excluded for each reason and each 
type of VP are listed in Table 1. 
This left 65 patients who could actually be included in our study, that is, who at the time 
of the first evaluation were still using the same type of VP as they had received in 
primary placement and thus were still in their assigned VP group. Unfortunately, due to 
the reasons listed in Table 1, the number of patients whose speech and voice rehabilitation 
progress could actually be evaluated differed across VP groups. The study included 21 
Groningen, 13 Nijdam and 31 Provox VP users. All of these patients were enrolled in a 
speech therapy program starting approximately 8 days post-operatively. Each patient 
followed the general therapy program, which consisted of three speech therapy sessions a 
week during the first three months, gradually decreasing to two and later one session a 
week during the next three to four months. The therapy program ended approximately six 
months after operation. We are aware of the fact that due to various reasons (e.g. a 
patient's inability to attend a therapy session as a result of general health problems, a 
patient's unwillingness to attend a session, a patient's skipping of a session because he/she 
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Table 1: Reasons for excluding patients from the study, number of patients excluded for 
each reason and each VP-type, and total number of patients excluded for each 
reason and each VP-type. GRO = Groningen, NW = Nijdam, PRO = 
Provox. 
Reason for exclusion 
change to other VP-type before any 
recordings 
VP removed before any recordings 
patient deceased before any recordings 
absence of recordings or refusal of 
patient 
trachea cánula or salivary bypass tube 
post-operative complications 
lost to follow-up 
total 
GRO 
0 
0 
2 
4 
0 
4 
1 
11 
NYD 
4 
1 
1 
6 
3 
4 
1 
20 
PRO 
0 
0 
1 
2 
1 
4 
1 
9 
total 
4 
1 
4 
12 
4 
12 
3 
40 
felt no need for it) the therapy program was not strictly controlled for each individual 
patient. But the average degree of experience with the assigned VP was comparable 
across the three VP groups. 
Recordings and speech materials 
To evaluate the progress of speech and voice rehabilitation, standard audio recordings 
were made at 4 to 6 weeks, 4 to 6 months and 9 to 12 months post-operatively. All 
recordings were monitored by the same speech therapist in order to ensure that in all 
recording sessions the same instructions were used and the same speech examples to be 
repeated were presented. Audio recordings were made using an AKG microphone (type 
C451E) at a set distance of 30 cm from the patient's mouth and a professional Studer 
recorder with recording level set at a fixed value. Intensity recordings (dB/A) were made 
using a Briiel & Kjaer intensity sound level meter (type 2225) with the microphone at a 
set distance of 30 cm from the patient's mouth. 
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In each recording session the patient was asked to perform the following standard 
speaking tasks: 
a. to repeat after the speech therapist a list of words with increasing number of 
syllables and consonant clusters; 
b. to read aloud a long sentence (24 syllables); 
с to repeat after the speech therapist a set of short sentences with an exaggerated 
intonation; 
d. to read out a text, a story with an approximate length of 120 words; 
e. to sustain the vowel /a/ as long as possible (this was done twice); 
f. to say the vowel /a/ as softly and as loudly as possible (also done twice); 
g. to say a short exclamatory sentence as softly and as loudly as possible (also done 
twice). 
The latter two speaking tasks were used to record the sound intensity levels. 
Evaluation scales, judges, and criteria 
The speech material for each patient and each recording session was evaluated on ten 
different scales, five objective measurements and five judgements". 
The five objective measurements taken (giving data at the ratio level) were as follows. 
1. Utterance size: the number of syllables spoken on one breath when uttering the long 
sentence (speaking task b). 
2. Phonation duration: the length in seconds of the sustained vowel /a/ (speaking task 
e), taking the longest of the two trial instances. 
3. Dynamic range on the tone: the difference in dB between the softest of the two soft 
realisations and the loudest of the two loud realisations of the vowel /a/ (speaking 
task f)· 
4. Dynamic range on the sentence: the difference in dB between the softest of the two 
soft realisations and the loudest of the two loud realisations of the exclamatory 
sentence (speaking task g). 
5. Speech rate: the number of syllables per minute as measured on the text (speaking 
task d). In establishing the total number of actually pronounced syllables, doubly 
pronounced syllables, e.g. when the patient made a restart of a sentence, did add to 
the total number, whereas syllables that were not pronounced did not. In establishing 
the total time to read the text, breathing pauses and natural intonational pauses were 
included but prolonged pauses, e.g. when the patient was cleaning his stoma or was 
having problems occluding it, were excluded. 
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The judgements were made by an experienced speech therapist familiar with tracheo-
oesophageal speech and by an experienced listener previously unexposed to this type of 
speech. The latter judge received an extensive training to get familiarized with the speech 
and the characteristics to be judged. Both judges listened to the tapes over loudspeakers in 
a sound isolated room and made their judgements independently. In those instances where 
the two judges disagreed they listened to the audio tapes together and tried to reach a 
consensus judgement, which was generally easily agreed upon. 
The five judgements made and the criteria used to establish their ordinal value were as 
follows. 
6. Availability of sound: judged on the list of words (speaking task a) repeated after the 
speech therapist. An average delay of about 3 seconds or less received the 
judgement 'good', an average delay of about 4 seconds or more was judged as 
'moderate', and if no or hardly any sound was produced the judgement was 'poor'. 
7. Fluency of speech: judged on the text (speaking task d). With no or hardly any 
hesitations and no or hardly any restarts the judgement was 'good', with some 
hesitations and restarts it was 'moderate', and with a lot of hesitations and restarts it 
was 'poor'. 
8. Overall intelligibility of speech: judged on the text (speaking task d). With almost 
everything intelligible the judgement 'good' was given, with few stretches hardly 
intelligible and/or unintelligible the judgement was 'moderate', and with quite a lot 
of stretches hardly intelligible and/or unintelligible the judgement was 'poor'. 
9. Voice quality: judged on the text (speaking task d). In judging this scale our two 
judges insisted on taking into account the quality of the voice as physically possible 
with the patient's PE-segment, that is the type of voice the patient can produce 
(which is not liable to change over time) and which they assessed as 'hypertonic or 
tense', 'normotonic', or 'hypotonic or lax', as well as the quality of the patient's 
technique in using the PE-segment, that is the type of voice the patient actually 
produces given his/her possibilities (which may improve over time) and which they 
also assessed as 'hypertonic or tense', 'normotonic', or 'hypotonic or lax'). For each 
of the judges separately, two 'normophonic' assessments resulted in a 'good' 
judgement for the voice quality scale, only one 'normophonic' assessment resulted in 
a 'moderate' judgement, and no 'normophonic' assessments in a 'poor' judgement. 
10. Stoma noise: judged on the text (speaking task d). No or hardly any noise due to air 
leakage and/or audible breathing was judged as 'good', some noise, but not 
constantly and not very loud, was judged as 'moderate', a lot of noise, either almost 
constantly or frequently very loud, was judged as 'poor'. 
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Of the ten scales six pertain to phonatory skills (1. utterance size, 2. phonation duration, 
3. dynamic range on tone, 4. dynamic range on sentence, 5. speech rate, and 6. 
availability of sound), two to speech quality (7. fluency of speech, and 8. overall 
intelligibility of speech), one to voice quality (9.), and one to stoma technique (10. stoma 
noise). As a means of evaluating the voice and speech rehabilitation progress in 
laryngectomees, the scales employed in this study have been used before8. 
RESULTS 
Actual and valid evaluations 
Ideally, we would have been able to evaluate each of the 65 patients actually included in 
our study at each of the three times planned, which would have given a total of 195 
instances of evaluation. Due to a number of reasons we were not able to obtain an 
evaluation for every single patient at each point in time. These reasons included: patient 
deceased after at least one evaluation was made (14 instances), medical complications at 
time of evaluation (9 instances), too weak to perform the task (3 instances), aversion to 
button speech (1 instance), refusal to cooperate (1 instance), VP removed (1 instance), 
evaluation performed too late (3 instances), or reason unknown (19 instances). Note that 
these numbers pertain to instances of evaluation (3 for each of the 65 patients) and not to 
patients. So, in a total of 51 instances no evaluation was performed, the number of actual 
instances of evaluation obtained was therefore 144. 
Of these 144 there were 14 instances in which a patient was actually evaluated but was 
unable to produce any sound at all at the time of evaluation. For these instances all scales 
were assigned the lowest value possible, '0' for the measurements, and 'poor' for the 
judgements. 
If the type of VP was changed during the study period (i.e. after the first evaluation with 
the type of VP of primary placement), the patient was considered to have dropped out of 
his/her VP group. Data from subsequent instances of evaluation (i.e. with a type of VP 
other than that primarily placed) were collected but not included in the study. This 
occurred for 5 patients and for these in a total of 7 instances: 1 initial Groningen VP user 
had been changed to a different VP at time point 3, and 4 initial Nijdam VP users had 
been changed to a different VP at either time point 2 and/or 3. These 7 instances of 
evaluation were considered invalid, so that the resulting number of valid evaluations came 
to 137. 
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The number of valid instances of evaluation for each VP group at each point in time is 
lower than the number of patients actually included in the VP group, and this number 
tends to decrease over time. At evaluation time 1 the lower number is due to the fact that 
no actual evaluation was performed, at evaluation times 2 and 3 it is due to either this 
same reason or to the fact that the actual evaluation was considered invalid because the 
patient had dropped out of the VP group because of change of type of VP. 
Table 2 gives, for each of the three types of VP, the number of patients actually included 
in the study, the number of valid evaluations at each evaluation time, as well as totals. 
Note that the numbers at the three evaluation times do not necessarily pertain to exactly 
the same groups of patients. 
Inter-judge agreement 
For each of the five judgement scales the inter-judge agreement was assessed. For this 
assessment the fact whether a certain instance of evaluation is valid or not (as defined 
above) is of no consequence, so all 144 actual evaluations were considered. Since no 
judgements were made in those 14 instances where patients were unable to produce any 
sound at all, these instances were excluded from the degree of agreement calculation. 
Of the remaining 130 evaluations there were 9 in which the patient could produce some 
words of the list (see 2.2, speaking task a), but failed to perform the rest of the speaking 
tasks. 
So, for these 9 patients only the availability of sound could be judged, and no judgement 
could be made for the other 4 judgement scales. 
Table 2: Number of patients actually included in the study (actual N), number of valid 
instances of evaluation at three points of time (valid N time 1, etc.) for three 
VP-types; and total numbers across VP-types and points in time. 
VP-type actual N valid N time valid N time valid N time valid N 
1 2 3 total 
Groningen 21 19 16 6 41 
Nijdam 13 11 6 5 22 
Provox 31 28 28 18 74 
Total 65 58 50 29 137 
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Consequently, the degree of agreement calculation for these 4 scales is based on 121 
observations. Table 3 summarizes, for each of the five judgement scales, the number of 
judgements given, the number of same judgements, and the degree of agreement in 
percentages (the ratio between same and given judgements). Although a difference to 
some extent may be observed for the five scales, we judged the degree of agreement 
(over 75 % in all cases) to be sufficiently high. 
Success rates for the individual evaluation scales 
Of the 10 individual evaluation scales 6 pertain to phonatory skills ('utterance size', 
'phonation duration', 'dynamics on tone', 'dynamics on sentence', 'speech rate', and 
'availability of sound'), two to speech quality ('fluency' and 'overall intelligibility'), one 
to voice quality and one to stoma technique ('stoma noise'). Design differences between 
the Groningen, Nijdam, and Provox VP's may lead to differences between the VP's on 
the scores for these individual scales. More specifically, the Provox VP, the voice 
prosthesis with the lowest resistance, might be expected to perform better on the scales 
pertaining to phonatory skills. 
For each of the five judgement scales a patient's performance at each point in time was 
considered 'successful' if the judgement was at least 'moderate'. For the five 
measurement scales performance was considered 'successful' if the following criteria were 
met: for utterance size 10 syllables or more, for phonation duration 4 seconds or more, 
for dynamic range on tone 15 dB or more, for dynamic range on sentence 10 dB or more, 
and for speech rate 100 syllables/minute or more. 
Table 3: Degree of agreement between the two judges for the five judgement scales. 
Judgement scale Judgements given Same judgements Degree of agreement 
127 97.69 % 
92 76.03 % 
98 80.99 % 
103 85.12 % 
106 87.60 % 
Total 614 526 85.67 % 
Availability of sound 
Fluency of speech 
Intelligibility of speech 
Voice quality 
Stoma noise 
130 
121 
121 
121 
121 
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Table 4: Success rates on the 10 individual evaluation scales in percentages (ratio of 
'successful ' speakers and valid evaluations) for three VP-types at three points in 
time. GRO-1 stands for Groningen VP at time 1, NYD-2 for Nijdam VP at time 
2, etc. 
Scale 
utterance size 
phonation duration 
dynamics on tone 
dynamics on sentence 
speech rate 
availability of sound 
fluency 
overall intelligibility 
voice quality 
stoma noise 
GRO-1 
63 
63 
63 
68 
47 
89 
58 
68 
68 
53 
GRO-2 
63 
69 
44 
50 
69 
81 
69 
63 
50 
63 
GRO-3 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
NYD-1 
64 
82 
78 
73 
64 
82 
82 
73 
55 
55 
NYD-2 
50 
100 
83 
83 
67 
100 
83 
83 
67 
83 
NYD-3 
100 
100 
60 
80 
100 
100 
100 
100 
80 
100 
PRO-1 
68 
64 
61 
75 
64 
79 
57 
64 
75 
36 
PRO-2 
79 
71 
75 
79 
79 
86 
75 
82 
82 
75 
PRO-3 
94 
78 
83 
78 
83 
94 
94 
89 
89 
78 
The values for these cut-off points are directly derived from Mahieu8 with some 
adjustment to allow for differences in the measurement procedure. 
For each VP and each point in time, success rate is defined as the ratio (in percentages) 
of 'successful' number and total number of valid instances of evaluation. Table 4 lists 
success rates for the 10 evaluation scales, for all three VP's at three points in time. 
Success rate for overall performance 
To evaluate the overall success as a tracheo-oesophageal speaker of a laryngectomized 
patient using a Groningen, Nijdam, or Provox VP, we needed to establish a score for 
overall performance. Such a score can be arrived at by weighing the scores for the 10 
individual scales, but this requires the scales to be of one and the same level. The highest 
common level for our scales is the ordinal level, so we were forced to reduce the interval 
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scales to ordinal ones. This was achieved as follows. For utterance size a score of 19 or 
more was considered as 'good', one of 10-18 as 'moderate', and one of 9 or less as 
'poor'. For phonation duration 10 seconds or more was considered as 'good', 4-9 seconds 
as 'moderate', and 3 seconds or less as 'poor'. For dynamic range on tone a difference of 
25 dB or more was labelled 'good', one of 15-24 dB 'moderate', and one of 14 dB or less 
'poor'. For dynamic range on sentence a difference of 20 dB or more was labelled 
'good', one of 10-19 dB 'moderate', and one of 9 dB or less 'poor'. For speech rate 140 
syllables/minute was considered 'good', one of 100-139 syllables/minute 'moderate', and 
one of 99 syllables/minute or less 'poor'. Again these cut-off points are directly derived 
from Mahieu8, with some allowance for differences in the measurement procedure. 
To arrive at a score for the overall performance scale, the scores on the 10 individual 
scales were weighed using the following rationale. A patient with at least 7 'good' scores 
and the remaining 3 scores at least 'moderate' received the overall assessment 'good'. A 
patient with at least 8 'good' or 'moderate' scores and the remaining 2 scores 'poor' 
received the overall assessment 'moderate'. A patient with 3 or more 'poor' scores 
received the overall assessment 'poor', irrespective of the scores on the other 7 scales. 
However, in order to prevent the dynamics judgements assessed on the two different 
speech materials (tone and sentence) to weigh too heavily in the final judgement, these 
were counted as only one ordinal scale, taking the lower of the two scores as the relevant 
one in those instances where the two differed. 
This resulted in a score on the overall performance scale for each of the valid evaluations. 
Overall performance was considered 'successful' if it was either 'good' or 'moderate'. 
Table 5 lists the numbers of valid evaluations, the numbers of 'poor', 'moderate', and 
'good', and 'successful' speakers on the overall performance scale, as well as the success 
rates, i.e. the ratio of 'successful' speakers and valid evaluations, for three voice 
prostheses at three evaluation times. 
Statistical analysis 
For the statistical analysis of longitudinal data and the assessment of change most studies 
apply an analysis of variance model (ANOVA) for repeated measurements. In terms of 
this well-known model, our design has one between-subject variable (VP-group) and one 
within-subject variable (time). The within-subject variable (time) reflects individual 
change that may or may not be affected by the between-subject variable (VP-group), so 
the score model should in fact be a 'growth model'. 
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Table 5: Success on the overall performance scale for the Groningen (GRÒ), Nijdam 
(NYD), and Provox (PRO) VP's at three evaluation points in time (GRO-1 
stands for Groningen VP at time 1, etc.): number of valid evaluations (valid N), 
number of'poor', 'moderate', 'good'and 'successful' speakers (poor N, etc.), 
as well as success rate in percentages (ratio of 'successful' speakers and valid 
evaluations). 
Overall 
performance 
valid N 
poor N 
moderate N 
good N 
successful N 
success rate 
GRO-I GRO-2 GRO-3 
19 16 6 
7 7 0 
8 7 1 
4 2 5 
12 9 6 
63% 56% 100% 
NYD-1 NYD-2 NYD-3 
11 6 5 
4 1 0 
5 4 3 
2 1 2 
7 5 5 
64% 83% 100% 
PRO-1 PRO-2 PRO-3 
28 28 18 
11 6 1 
13 14 10 
4 8 7 
17 22 17 
61% 79% 94% 
The model for ANOVA with repeated measurements has a number of drawbacks 
associated with three assumptions underlying this approach, namely: 
equal variances: variances of the differences between the levels of the within-subject 
factor (time) are assumed to be equal; this assumption is not a realistic one, subjects may 
be expected to diverge in their scores in the course of time; 
equal growth rates: growth rates for individual subjects are assumed to be equal; this 
assumption, too, is not realistic, subjects tend to exhibit individual growth rates; 
equal time spacing: spacing between measurement occasions and number of occasions are 
assumed to be equal; again, this assumption is not realistic, especially the last one, since 
missing data do occur. 
However, a fairly recent statistical technique, known as Hierarchichal Linear Modelling9, 
is specifically designed to deal with this type of data. It is a two-level technique based on 
regression equations and each level is characterized by its own model. The within-subject 
model at level-1 models the subject's individual growth trajectory as a function of time in 
terms of intercept and slope parameters. The between-subject model at level-2 models the 
parameters of the level-1 model as a function of the group variable VP. A t-statistic test is 
used to assess whether this predictor (VP-group) affects overall score, improvement over 
time, and/or the interaction between the two. 
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The HLM-analysis was performed for all 10 individual scales and for the overall 
performance scale. Of course, only valid observations (valid as defined in section 3.1) 
were entered into this analysis. For the judgement scales the ordinal values 'good', 
'moderate', 'poor' were replaced by the numerical values 3, 2, 1, respectively. (Any 
other numerics would have resulted in the same results). For the measurement scales the 
interval data (numerical values) were used as input. The results showed no significant 
effect for the main factor 'type of VP' for any of the 10 individual scales, nor for the 
overall performance scale. The effect of the main factor 'time' was statistically significant 
for only two scales, speech rate (p<0.05) and stoma noise (p<0.01); a tendency for a 
main 'time' effect (0.05 <p<0.10) was observed for the fluency and overall intelligibility 
scales, and for the overall performance scale. As for the interaction between 'type of VP' 
and 'time', no significant effects were observed. 
DISCUSSION 
From the figures in Table 2 it is clear that the number of valid evaluations does 
substantially drop from the first evaluation time to the second evaluation time for the 
Nijdam VP, and from the second evaluation time to the third evaluation time for the 
Groningen and Provox VP. A qualitative assessment reveals that the reduction in valid 
evaluations for the Nijdam VP is mainly due to reasons of 'change to different VP' or 
'patient deceased after first recording'. The reduction in valid evaluations for the 
Groningen VP and the Provox VP is mainly due to 'patient deceased after first 
recording', 'reason unknown' or 'other'. 'Other' reasons included 'too weak to perform 
the task', 'recordings made too late', 'refusal to cooperate', 'aversion to button speech', 
or 'VP permanently removed'. 
This poses some interesting questions as to the interpretation of our results. For example, 
it can be conceived that an improved performance of the Nijdam VP patients from 
evaluation time 1 to evaluation time 2 is due to the fact that a 'better' group remains. 
Namely, the reasons why patients dropped out ('change to different VP' or 'patient 
deceased after first recording') may suggest that these drop-outs were not destined to be 
successful speakers at any later time. With respect to 'patient deceased after first 
recording', the same argument would hold for the differences between evaluation time 2 
and evaluation time 3 for the Groningen and Provox VP's. On the other hand, patients 
that were not evaluated because of 'reason unknown', or 'other' may, conceivably, have 
done well on the evaluation scales employed, which may have resulted - if these 
evaluations could have been included in our study - in a tilting of the score on the overall 
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performance scale to a more positive outcome. 
While interpreting our results, it should also be taken into account, that the number of 
valid evaluations at time 3 for the Provox VP is considerably higher than that for the 
other two VP's. A higher number of observations does not only yield more reliable 
results, but is also more liable to reveal possible individual differences. Moreover, the 
ratios between the valid evaluations at time 3 and those at time 1 (31.58% for the 
Groningen VP, 45.45% for the Nijdam VP, and 64.29% for the Provox VP) show that 
the evaluative power over time is not the same for the three VP's. 
In view of all this, we propose that any conclusions to be drawn with respect to the effect 
of the type of VP can only be tentative. 
The degree of agreement between the judges is high, over 75% for all scales. Moreover, 
in those cases where the judges disagreed a consensus judgement was generally easily 
agreed upon. 
With regard to the results for the 10 individual scales employed: although the data in 
Table 4 might suggest a difference between the three types of VP, at least for some of the 
evaluation scales, the main factor 'type of VP' was not significant for any of these scales. 
Also, the expectation of an advantage for the Provox VP (on the basis of its relatively 
lower resistance) on the scales pertaining to phonatory skills is not met, suggesting that 
the lower resistance in this type of VP does not substantially add to performance on this 
type of skills. The significant (positive) effect of the main factor 'time' for the speech 
rate and stoma noise scales, and the not-significant (positive) trend for this 'time' factor 
for the fluency and overall intelligibility scales suggest that these skills are particularly 
likely to improve with more experience with the type of VP. 
As for overall performance, it can be seen from Table 5 that success rates for all three 
VP's increase over time from about 60-65% for time 1, through about 80% for time 2 
(with only the Groningen VP lagging behind), to a virtual 100% for time 3. 
So, with the possible exception of the Groningen VP at time 2, the three VP's yield a 
similar result. 
Lastly, since neither the main effect of 'VP-type' nor the interaction between 'VP-type' 
and 'time' is significant for any of the evaluative scales, there seems to be no objection to 
interpreting the results for the three different VP's at time point 3 as being obtained for 
just one (i.e. the same) VP. This allows us to establish a 'normal' value for each of the 
five measurements at the end of the study period (well after therapy end). 'Normal' to be 
understood as normal for a 'successful' speaker producing tracheo-oesophageal speech by 
means of a low-resistance VP (either Groningen, Nijdam, or Provox VP). 
62 
A prospective study of speech and voice 
Table 6: Means and standard deviations for five objective measurements of phonatory 
skills, as obtained for speakers using tracheo-oesophageal speech with a low-
resistance VP (either Groningen, Nijdam, or Provox). Only the 31 speakers 
evaluated as 'successful' on overall performance at evaluation time 3, 
irrespective of the actual VP in situ, were included in these calculations. 
Evaluation scale Mean S.D. 
Utterance size (number 19.6 5.1 
ofsyllables) 
Phonation duration (seconds) 7.9 3.6 
Dynamics on tone (dB) 17.6 5.1 
Dynamics on sentence (dB) 15.4 5.7 
Speech rate (syllables/minute) 157.2 36.4 
For each of the five measurement scales, we calculated means and standard deviations 
over all 'successful' patients at time point 3, irrespective of the type of VP. The obtained 
values for these five objective measurements may be taken as a guideline for what can be 
attained with 'successful' speakers using tracheo-oesophageal speech, that is the targets to 
be at least attained at 10 months post-operatively. The means and standard deviations for 
the five measurements are listed in Table 6. 
CONCLUSIONS 
Firstly, we would like to state that we are aware of the fact that, due to the unbalanced 
numbers of valid instances of evaluation across both 'VP-type' and 'time' of evaluation, 
the following conclusions can only be of a tentative nature. 
Secondly, it would appear from the above that the type of VP does not give rise to any 
differences in performance, as measured by our evaluation scales. Moreover, VP-type 
does not affect the rate of improvement over time. So, the final result of the speech and 
voice rehabilitation process, at least as measured by our evaluation scales, does not 
depend on the type of VP used. 
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Thirdly, judging from the virtually non-existent differences between the three types of 
VP's with regard to success rates, we conclude that this study does not - at least not on 
the basis of the results here - give clear guidance as to the type of VP to be chosen, i.e. if 
the choice is between the Groningen, Nijdam, and Provox low-resistance VP's. So, it 
would appear that considerations as to a patient's final speech performance, i.e. after the 
end of the speech therapy, do not necessarily have to be taken into account when making 
the choice between these three VP-types. On the other hand, this choice may still be 
guided by other factors, such as a patient's comfort with the VP, replacement rate of the 
VP, financial reasons, etc.10. 
Fourthly, in view of the differences in the aerodynamic characteristics of the three VP-
types, and taking into account that our results did not differentiate between the three, it 
seems justified to question whether research into prostheses with even lower resistances is 
still warranted. 
Finally, for most evaluation scales no improvement over time was observed. So, for most 
speaking skills, the final level of performance is reached quite early in the rehabilitation 
process. Speech rate and stoma noise are the two exceptions, but it is our impression that 
the improvement over time of these two skills is stimulated by speech training. So, on the 
whole we view the results of this study as representing an argument for an intensive 
rather than an extensive post-operative speech therapy. 
This study shows that prosthesis-assisted tracheo-oesophageal speech is a highly 
successful method of rehabilitating laryngectomees, but there is still a significant number 
of patients, about 10% in our study that, for various reasons, are not eligible for primary 
placement of a voice prosthesis. Although some of these patients will be reconsidered for 
secondary placement, they will depend on oesophageal speech or the aid of an 
electrolarynx for a significant time in the very important post-operative period. It should 
be stressed that these options are still very helpful in selected cases, and thus that these 
skills should not be lost. 
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ABSTRACT 
Tracheo-oesophageal speech is currently the most successful form of voice and speech 
rehabilitation for laryngectomees. The use of various voice prostheses has become widely 
accepted. Main inter-device differences are the device lifetime and the trans-device 
pressure loss during speech. 
The valveless indwelling Nijdam voice prosthesis is a new voice prosthesis. A barrier 
mechanism is realized by a combination of the oesophageal mucosa and the 'umbrella-like 
hat' of the Nijdam voice prosthesis that covers the oesophageal side of the tracheo-
oesophageal fistula. The Nijdam voice prosthesis has a long device lifetime compared to 
other indwelling voice prostheses like the Provox voice prosthesis and the low-resistance 
Groningen voice prosthesis. However, the trans-device pressure loss during speech was 
unknown. 
Adjustment of the shaft length of the Nijdam voice prosthesis to the tracheo-oesophageal 
wall thickness was expected to affect the trans-device pressure loss during speech. We 
report the results of in vitro tests to quantify the effect of tracheo-oesophageal wall 
thickness on trans-device pressure loss. In the present study pressure loss was measured at 
different airflow rates in relation to tracheo-oesophageal wall thickness. Findings 
demonstrated that when the shaft length of the Nijdam prosthesis corresponded exactly to 
tracheo-oesophageal wall thickness, trans-device pressure loss was comparable to that of 
the Provox prosthesis. If a relatively shorter Nijdam prosthesis was chosen to prevent 
aspiration from occurring, the pressure loss across the prosthesis increased to that of the 
low-resistance Groningen prosthesis. 
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INTRODUCTION 
Voice prostheses (VP's) have now been employed over the last 16 years to restore speech 
after total laryngectomy. The first commercially available prosthesis was developed by 
Blom & Singer in 19791. VP's are inserted in a surgically created fistula in the tracheo-
oesophageal wall (TOW). At initiation of voice, the tracheostoma has to be occluded 
manually or by means of a tracheostoma valve2. Expiratory air then flows into the 
oesophagus to activate the pharyngo-oesophageal segment. 
Two types of VP's can be distinguished, i.e. non-indwelling and indwelling devices. The 
former devices can be replaced by the patient; the latter remain in place until the end of 
the device lifetime, which is generally indicated by either leakage or increased airflow 
resistance. The indwelling VP should be replaced as an outpatient clinic procedure by an 
otorhinolaryngologist. 
The indwelling Nijdam VP is produced and distributed by Medin Instruments (Groningen, 
The Netherlands) and has been used clinically in the ENT Department of the Unievrsity 
Hospital Nijmegen (The Netherlands) since 19885. 
The Nijdam VP explicitly differs from other indwelling VP's3·8 because the Nijdam VP is 
valveless in itself. It's barrier mechanism is realized by an 'umbrella-like hat' that covers 
the tracheo-oesophageal (TO) fistula on the oesophageal side. It was expected that the 
shaft length of the Nijdam VP would influence the tension between the silicone 'hat' and 
oesophageal mucosa. The trans-device pressure loss during speech will therefore be 
influenced by adjustment of the shaft length of the Nijdam VP to the TOW thickness. In 
this paper the influence of TOW thickness on the trans-device pressure loss at 
physiological airflow is presented. 
In vitro measurements are performed using a measuring set-up with a dummy TOW. A 
change of TOW thickness was simulated artificially. The trans-device pressure loss was 
measured at different airflow rates and related to the TOW thickness. 
Finally the in vitro properties of the Nijdam VP were compared to other indwelling VP's. 
MATERIALS 
The Nijdam voice prosthesis 
The Nijdam VP is shown schematically in Figure 1. It consists of a tracheal and a smaller 
oesophageal flange, connected by a shaft. On top, a 'hat' is connected to the oesophageal 
flange by three small columns. The overall dimensions of the Nijdam VP are shown in 
Figure 1. 
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13 mm 
Figure 1: Schematical representation of the Nijdam VP. 
A: cross section, B: top view (the dotted lines mark the columns); 
1: tracheal flange, 2: oesophageal flange, 3: umbrella-like 'hat', 4: column, 
S.I.: shaft length. 
oesophageal side 
)°o0ooooo ï ïo°oo 
>°o0o0o0o0o°o0 liiil lili 
tracheal side 
Figure 2: Nijdam VP in situ. At rest the umbrella-like 'hat' deforms the oesophageal 
mucosa. During phonation deformation of the 'hat' and the mucosa is shown by 
the dotted lines. Arrows indicate the direction of the airflow during phonation. 
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The prosthesis is made from medical-grade silicone rubber and is molded in one piece. It 
is available in 5 shaft lengths, i.e. 4 to 8 mm and 2 shaft diameters, 7 and 8 mm, to meet 
the individual differences in TOW thickness and diameter of the TO fistula, respectively. 
Figure 2 shows a schematical drawing of the Nijdam VP in vivo. It also shows the barrier 
mechanism of the prosthesis: increased tracheal pressure on attempted phonation, causes 
deformation of both the 'hat' and the oesophageal tissue (Figure 2), so expired air can 
flow from the trachea through the shaft into the oesophagus. 
The experimental set up 
The experimental set up (Figure 3) consists of a housing in which a Nijdam VP is placed. 
To reproduce the interaction of the 'hat' of the Nijdam VP with the oesophageal tissue, 
we used a part of the oesophagus of a pig, consisting of both mucosal and muscular 
layers. To simulate reality as close as possible we performed experiments within two 
hours after sacrificing the pig. 
Plastic disks were used to increase the thickness of the TOW to simulate a relatively 
small VP inserted in the TOW. 
The housing was equipped with a pressure and flow transducer (Aerophone II system, 
model 6800, KAY Elemetrics Corp, Pine Brook, NJ, U.S.A.) which was connected to a 
computer all data were stored on disk. 
METHODS 
A piece of porcine oesophagus of about 4 cm2 was pierced with a scalpel. A Nijdam VP 
with a shaft length exceeding the TOW thickness was inserted in the perforation. Both 
parts were placed into the test housing and a water level of 2 cm was placed above the 
VP hat to check for possible leakage. If necessary, leakage was controlled by assembling 
the two halves of one or more plastic disks underneath the oesophageal specimen (Figure 
3). The corresponding artificial TOW thickness, was used as reference thickness 
(TOWfjf). Measurements were carried out for increasing TOW thicknesses using plastic 
disks of 0.5 mm thickness until a maximal increase of 2.5 mm was reached. Human 
expiratory air was blown through the device at various discrete flow rates increasing from 
about 0.05 1/s to 0.5 1/s. Each flow rate was kept constant for a few seconds. The trans-
device pressure loss was measured for each flow rate at various TOW thickness rates and 
recorded as an X-Y graph. 
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Figure 3: Experimental setting for testing with connections to the pressure transducer (A) 
and the flow head (B). 1: housing, 2: Nijdam VP, 3: porcine oesophagus, 4: 
plastic disks of 0.5 mm thickness. 
The effect of the TOW thickness increase on the trans-device pressure loss was studied at 
a flow of 0.15 1/s, the average conversational flow of tracheo-oesophageal speakers. The 
corresponding trans-device pressure loss was obtained by linear interpolation. 
Airflow measurements were carried out on three Nijdam VP's, each time using a fresh 
piece of porcine oesophagus. 
Results were compared to previously published results of the standard Groningen VP, the 
low-resistance Groningen VP6 and the Provox VP3. 
RESULTS 
Trans-device air pressures losses of one representative experiment are plotted against flow 
rates for different TOW thicknesses (Figure 4). 
72 
Aerodynamic characteristics of the Nijdam voice prosthesis 
Trans-device pressure loss (kPa) 
TEW thickness 
increase (mm) 
~-o.o 
+ 0.5 
^ 1 . 0 
• 1 . 5 
^ 2 . 0 
-•-2.5 
0.1 | 0.2 
0.15 
0.3 0.4 0.5 0.6 0.7 
Air flow rate (l/s) 
Figure 4: Trans-device pressure loss versus airflow rate of one experiment. The TOW 
thickness is increased five times by using plastic disks of 0.5 mm thickness. 
The effect of an increasing TOW thickness on the trans-device air pressure loss at a 
physiological airflow of 0.15 l/s is depicted in Figure 5. The mean of three experiments 
and the maximal variation is given. Also the trans-device air pressure loss for an airflow 
of 0.15 l/s of the standard Groningen VP3, the low-resistance Groningen VP3 and the 
Provox VP3 are shown. The first leakage proof situation (TOWref) showed a mean 
pressure difference of 0.86 kPa (at a flow rate of 0.15 l/s) which is comparable to that of 
the Provox VP (0.67 kPa). When the TOW thickness was increased, the mean pressure 
difference increased from 1.1 kPa (TOWref+05) to 1.5 kPa (TOWref+10). The pressure loss 
of 1.5 kPa (TOWref+10), is comparable to that of the low-resistance Groningen VP (1.68 
kPa). 
Further enlargement of the TOW thickness caused a mean trans-device pressure loss from 
2.7 kPa (TOWref+15), 2.9 kPa (TOWref+20) to a maximum of 3.5 kPa (TOWref+2,5). The 
pressure difference of TOWref+2 (2.9 kPa), is comparable to that of the standard 
Groningen VP (3.15 kPa). 
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Figure 5: Trans-device pressure loss at a physiological airflow rate of 0.15 l/s related to 
TOW thickness increase. Also the trans-device air pressure loss is shown at the 
airflow rate of 0.15 l/s of the standard Groningen VP (SG VP), the low-
resistance Groningen VP (LRG VP) and the Provox VP. 
Maximum standard error in all measurements was ± 0.2 kPa. In none of the cases 
leakage appeared. The fact that the relation between increase in TOW thickness and 
increase of trans-device pressure loss is not linear (Figure 4) is probably caused by visco-
elastic properties of the applied soft tissue. 
DISCUSSION 
Most laryngectomized patients can regain their speech using a VP for TE speech. The VP 
is inserted in a surgical created TE fistula. It enables airflow from the trachea into the 
oesophagus when the tracheostoma is occluded. This airflow causes vibration of the PE-
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segment which leads to phonation. The VP prevents leakage from the oesophagus into the 
trachea and stenosis of the fistula. Although most laryngectomized patients are very 
enthusiastic about rehabilitation with VP's, drawbacks still remain. 
First, the clinical lifetime of the VP is limited, especially when contaminant organisms 
(such as candida or yeast) adhere on the valve7. This causes leakage and/or increased 
pressure loss, requiring replacement of the VP by a physician. This takes time and money 
and is unpleasant for the patient. 
Secondly, high intra-tracheal pressure needed for phonation can tire certain patients. This 
intra-tracheal pressure is mainly caused by both the PE-segment and the VP. Thus, trans-
device pressure loss must be low to decrease intra-tracheal pressure. 
Because of the inter-device difference in susceptibility of the valve mechanism to candida 
and yeast induced deterioration, device lifetime and in vivo airflow resistance vary. 
Considering device lifetime, the Nijdam VP can be qualified as a good VP; mean lifetime 
was found to be 19 weeks4. The same study presented a mean lifetime of the Provox VP 
and the low-resistance Groningen VP of 13 and 15.8 weeks respectively. The relative 
long device lifetime of the Nijdam VP is probably due to the fact that the barrier 
mechanism (oesophageal mucous membrane versus silicone rubber) is less disturbed by 
candida and yeast induced deterioration. 
When considering trans-device pressure loss it appeared that, when the shaft length of the 
Nijdam prosthesis equals the thickness of the TOW, the in vitro properties of the Nijdam 
VP during speech resemble the Provox VP characteristics. One can question whether this 
adjustment is possible in vivo, and if so, whether it will result in a leakage proof situation 
under changing conditions as when swallowing. 
However, we have also shown that when the shaft length of the Nijdam VP is decreased 
by 1 mm (comparable to the situation of TOWref+10), this tighter fit will still result in a 
very acceptable airflow resistance resembling the low-resistance Groningen VP. 
Aspiration will most probably not occur in this situation. 
Only when the shaft length of the Nijdam VP is 2 mm shorter (TOWref+2 0) compared to 
the first leakage proof situation, the airflow resistance rises to a level comparable to the 
airflow resistance of the standard Groningen VP, which is now considered undesirable. 
The shaft length of the Nijdam VP appears to be critical for the airflow resistance of the 
barrier mechanism. This causes intra-individual trans-device pressure loss differences 
during speech that do not occur when other VP's are applied. 
Applying the proper size of VP for each individual is essential for optimal functioning of 
the Nijdam VP. In addition to the experience of the physician, a measuring device to 
measure the TOW thickness before placement could be helpful. 
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In conclusion, when the size of the Nijdam VP corresponds optimally to TEW thickness, 
the trans-device pressure loss of the Nijdam VP during speech is comparable to that of 
the Provox VP. However, to prevent the risk of aspiration a smaller version of the 
Nijdam VP should be inserted. This will result in an acceptable trans-device pressure 
loss, comparable to that of the low-resistance Groningen VP. Inserting an even smaller 
Nijdam VP will result in an unacceptable pressure loss comparable to the standard 
Groningen VP and should therefore be avoided. 
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ABSTRACT 
The Nijdam voice prosthesis is an indwelling valveless voice prosthesis for post-Iaryngec-
tomy voice rehabilitation. The in vitro aerodynamic characteristics are reported to be 
comparable to that of the low-resistance Groningen voice prosthesis. Due to the design of 
the prosthesis the airflow resistance depends on the shaftlength of the voice prosthesis in 
relation to the thickness of the tracheo-oesophageal wall. As tissue characteristics of the 
patients oesophageal mucosa could also be of importance an in vivo study was found 
necessary. To assess in vivo characteristics the following parameters were recorded in 10 
patients: intra-tracheal pressure, intra-oesophageal pressure and airflow during phonation. 
At an airflow of 0.15 L/s the trans-device pressure loss varied from 0.5 up to 7 kPa 
(mean 3.9 kPa). With artificial increase of the tracheo-oesophageal wall thickness trans-
device pressure losses up to 13 kPa were found. Significant interindividual as well as 
intraindividual differences were noted. The airflow resistance of the Nijdam voice 
prosthesis in relation to the thickness of the tracheo-oesophageal wall was compared with 
the airflow resistance reported for various other voice prostheses. 
The in vivo aerodynamic characteristics of the Nijdam voice prosthesis found in this study 
indicate the need to modify the present design in order to improve its airflow resistance 
and to eliminate the influence of the thickness and tissue characteristics of the tracheo-
oesophageal wall. 
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INTRODUCTION 
The concept of voice prosthesis (VP) assisted tracheo-oesophageal speech is well-known 
and highly successful in rehabilitating the majority of laryngectomized patients1·2·3. Since 
the introduction of a commercially available VP by Blom and Singer in 19794 several 
other devices have been brought to our attention5-6·7. With the presentation of the low-
resistance Provox VP7 the importance of a low airflow resistance again was stressed. 
Most leading devices8·910 have been adapted in order to achieve more favourable 
aerodynamic characteristics. At present an acceptable prosthesis should be an indwelling 
low-resistance device as it combines a low complication rate with an optimum chance for 
effortless and fluent speech. 
The Nijdam VP is a valveless voice prosthesis that became commercially available in 
1990. Recently the Nijdam VP has been officially described in the literature". We have 
been using the Nijdam VP since its introduction and have compared it prospectively with 
the Groningen VP and Provox VP12·13. 
The aerodynamic characteristics of the Nijdam VP have been a point of discussion as 
theoretically the opening pressure could be unpredictable due to the design of the valve 
mechanism, the shaftlength of the VP, the thickness of the tracheo-oesophageal wall 
(TOW) and the pliability of the patients oesophageal mucosa. As the valveless Nijdam VP 
forms a barrier mechanism with the oesophageal mucosa the aerodynamic characteristics 
can only be accurately defined in a model simulating the in vivo situation or in an in vivo 
setting. The effect of the thickness of the TOW in relation to the shaftlength of the 
Nijdam VP has been tested in an in vitro model using porcine oesophagus. Aerodynamic 
characteristics of the Nijdam VP were reported to be comparable to that of the low-
resistance Groningen VP14. Recent biomechanical studies on the Nijdam VP have shown 
that with increasing intra-tracheal pressure a tracheo-oesophageal opening is not only 
created by deflection of the oesophageal flange of the Nijdam VP, but also by 
deformation of the oesophageal mucosa15. This suggests that tissue characteristics of the 
oesophageal mucosa can influence the airflow resistance of this VP. The pliability of the 
oesophageal mucosa might differ in laryngectomized patients due to prior surgery or 
radiotherapy. For this reason an ¡n vivo study has been designed in addition to our study 
using porcine oesophagus. 
This article describes the method used and results of these in vivo measurements. 
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Figure 1: Schematic drawing and dimensions (mm) of the Nijdam voice prosthesis. 
MATERIAL AND METHODS 
* the Nijdam VP 
The Nijdam VP is a bi-flanged valveless medical-grade silicone VP with a completely 
new barrier mechanism. The Nijdam VP is shown schematically in figure 1. The inner 
surface of the oesophageal flange has an open connection to the lumen of the shaft and 
the tracheal opening. In vivo the edge of the oesophageal flange is in contact with the 
oesophageal mucosa and thus a barrier is formed. When phonation starts increased intra-
tracheal pressure deforms both the oesophageal flange and the oesophageal tissue, thus 
opening the barrier mechanism (Figure 2). Therefore it is important to relate the 
shaftlength of the VP to the TOW thickness. If the prosthesis is too short, it will fit too 
tight causing an increase of the opening pressure. If the VP is too long leakage may 
occur. 
The Nijdam VP is available in 5 shaftlengths, 4 to 8 mm, and 2 shaftdiameters, 7 and 8 
mm. This enables adjustment to individual differences in TOW thickness and diameter of 
the tracheo-oesophageal fistula. 
*experimental setup 
The size of the shaftlength in relation to the thickness of the TOW is known to influence 
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oesophageal side 
tracheo-oesophageal wall 
tracheal side 
Figure 2: The Nijdam voice prosthesis 'in vivo '. The arrows indicate airflow during 
speech. The deflection of the oesophageal flange and impression of the 
oesophageal mucosa during speech are represented by the interrupted lines. 
the trans-device pressure loss14. In order to gain insight in this effect in vivo, Nijdam 
VP's with different shaftlength's should be tested, as the TOW thickness cannot be 
changed. 
Repeated replacements might cause oedema of the fistula region and oesophageal mucosa. 
This will influence the trans-device pressure loss as the oesophageal mucosa is part of the 
barrier mechanism of the Nijdam VP. For this reason and to minimize discomfort for our 
patients we replaced the in situ VP at initiation of the experiment by a new Nijdam VP, 
preferably with a longer shaftlength than the in situ VP. During the experiment the 
shaftlength of the VP in relation to the thickness of the TOW was altered by placing a 1, 
2 or 3 mm thick silicone disk between the tracheal flange of the VP and the posterior 
tracheal wall (Figure 3). In this way the effect of four different shaftlengths (or TOW 
thicknesses) on the trans-device pressure loss could be evaluated with only one VP 
replacement in each participating patient. 
The intra-oesophageal pressure was measured with a 5F Miller microtip pressure 
transducer (model 350, serial nr 2394, Miller instruments) inserted through the nose. The 
microtip was located at the level of the oesophageal flange of the VP, which was 
approximately 25 cm from the nostril. 
81 
Chapter б 
Figure 3: Placement of a silicone disk between tracheal flange and tracheal mucosa. A 
forceps is fed through the silicone disk (left). The tracheal flange of the in situ 
voice prosthesis is grasped and folded with the aid of the forceps (middle). The 
silicone disk is pushed over the tracheal flange (right). 
The location was checked endoscopically and adjusted if necessary. A thin catheter tube 
was inserted into the tracheostoma and taped to the skin surrounding the stoma. During 
phonation it was kept in place by the finger occluding the stoma. The catheter was 
connected to the pressure transducer in the Aerophone mask, designed to measure 
intraoral pressure, now measuring the intratracheal pressure. Trans-device pressure loss 
was obtained from a custom made electronic subtractor by subtracting the momentary 
values of the intra-oesophageal pressure from the momentary values of the intratracheal 
pressure. The intra-tracheal pressure transducer and the face mask containing a flow 
transducer were connected to the Aerophone II system (AP2) (Aerophone II system, 
model 6800, KAY Elemetrics Corp), USA). The AP2 system was connected to a 486 DX 
IBM compatable portable computer. An eight channel writer (type MT 9500 Recorder 
Astromed), was set at a paperspeed of 5 mm/sec and was connected to an intratracheal 
and intra-oesophageal pressure transducer and an electronic subtractor. The intra-tracheal 
pressure transducer was used to trigger both the AP2 and the MT 9500 system. The 
experimental setup is shown in figure 4. 
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Figure 4. Arrangement of apparatus used for in vivo measurements. 
The following in vivo parameters were recorded: 
(a) intra-tracheal pressure during phonation 
(b) intra-oesophageal pressure, at the level of the oesophageal flange of the VP, during 
phonation. 
(c) trans-device pressure loss: calculated by subtracting (b) from (a) 
(d) airflow during phonation 
Before each experiment the complete system was calibrated against a water manometer 
and a known airflow rate. 
*patients 
Ten laryngectomized patients, considered to be successful tracheo-oesophageal 
speakers2·13, were selected and invited to participate in the experiment. They were fully 
informed about the experiment and the freedom to refuse participation without reasoning 
why and without consequences. Oral consent was obtained from all. Travel expenses were 
compensated for. 
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The in situ VP was removed under topical anaesthesia and replaced by a Nijdam VP with 
a longer shaftlength. The patient was asked to swallow some water in order to check for 
leakage. The intra-tracheal and intra-oesophageal pressure transducers were inserted and 
fixed. The patient was instructed how to use the face mask with one hand and occlude the 
tracheostoma with the other. He was allowed to practise a few times while checking for 
air leakage. 
The new VP was inserted approximately half an hour before the actual experiment started 
in order to let the VP acquire body temperature and become moist. 
The patient was instructed to place the mask airtight to his face, covering mouth and 
nose. After leakage of air was checked, the patient was asked to produce a sustained 
vowel /a/ at a soft, normal and loud sound pressure level. This was done twice. After 
insertion of a 1, 2 or 3 mm silicone disk respectively, the complete procedure was 
repeated. Leakage of the VP was checked for all instances prior to each recording. The 
first leakproof situation was called tracheo-oesophageal wall increase zero (TOW 0). This 
corresponds to a situation were the shaftlength of the VP and the TOW thickness are 
approximately equal. 
After the experiment a new properly sized Nijdam VP was inserted. 
RESULTS 
Two patients were using a 10 mm Provox VP prior to the experiment. One of them could 
not pass air with the largest available Nijdam VP (8 mm) due to the thickness of his 
tracheo-oesophageal wall. As no recordings could be made, he was excluded from the 
study. Data obtained from the second patient will be discussed below. 
Figure 5 typically shows the results of the experiment in one patient. The trans-device 
airpressure loss for TOW increase of 0, 1, 2 or 3 mm in relation to airflow is depicted. 
Addition of a 1 mm disk does not yet give an increase of trans-device pressure loss which 
confirms that the first measurement was done with a VP with a shaftlength that was too 
long. Adding a 2 or 3 mm silicone disk increases trans-device pressure loss. 
The trans-device pressure loss, at an airflow of 0.15 L/s10, as a function of increase of 
TOW thickness in 9 patients is shown in figure 6. TOW increase 0 mm reflects the first 
leakproof situation during the experiment. If the first leakproof situation occurred with a 
1 mm silicone disk only TOW increase 0, 1 and 2 mm are reflected (Figure 6). The mean 
trans-device pressure loss for a TOW increase of 0, 1, and 2 mm was 2.7 kPa, 3.9 kPa 
and 6.2 kPa respectively with a standard deviation of 2.1 kPa, 2.0 kPa and 1.9 kPa 
respectively. 
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Figure 5: Example of trans-device pressure loss against airflow in one patient with a 
Nijdam VP showing the effect of the addition of a 1, 2 or 3 mm silicone disk. 
Trans device pressure loss (kPa) 
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TOW increase (mm) 
Figure 6. Trans-device pressure loss against tracheo-oesophageal wall increase for an 
airflow of 0.15 Lis for all included patients. Also shown the results of the in 
vitro measurements reported previously (dashed line). 
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The line at the top represents the second patient previously fitted with a Provox VP with 
a shaftlength of 10 mm. A Nijdam 8 mm VP (TOW increase 0 mm) was known to be too 
small for this patient. Adding silicone disks led to very high pressures. Trans-device 
pressure loss ranged from 6.5 kPa to almost 13 kPa. The results of our in vitro study14 
are also shown in figure 6. They compare favourable to the in vivo results. 
Figure 7 shows the in vivo trans-device pressure loss (kPa) against airflow (L/s) for the 
Nijdam VP with TOW increase of 0, 1 and 2 mm. Standard deviations are indicated by 
interrupted lines. Also incorporated in this figure are the values of the Provox VP, low-
resistance Groningen VP and the Blom-Singer low-resistance VP10 that have been reported 
previously. 
Trans device pressure loss (kPa) 
^ " 0 mm 
•" 1 mm 
-*-2 mm 
"^ " Provox 
"*" Groningen 
"*" Blom-Slnger 
0 0,05 0,1 0,15 0,2 0,25 0,3 0,35 
Air flow (l/s) 
Figure 7: Mean trans-device pressure loss against airflow for tracheo-oesophageal wall 
increase 0, I and 2 mm. Vertical bars indicate standard deviations. 
Comparable values of the low-resistance Groningen, Provox and the Blom-
Singer low-resistance voice prostheses. 
DISCUSSION 
The Nijdam VP is a valveless VP that forms a barrier in combination with the oesophage­
al mucosa. As it is a selfretaining, biflanged VP, the pressure of the oesophageal flange 
on the mucosa, which in part determines the airflow resistance of this VP, depends on the 
I и 
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shaftlength of the VP in relation to the TOW thickness. Therefore we varied the shaft-
lenght in relation to the TOW thickness during the experiment. 
TOW thickness 0 mm reflects the first leakproof situation during the experiment. It might 
still be questionable whether the closure for fluids is tight enough to prevent leakage in all 
circumstances. Therefore the most important values are given for TOW increase 1 mm. 
In only two patients test results comparable to the in vitro test results of the Nijdam VP 
were measured. In the other patients trans-device pressure losses up to 7 kPa, under no 
leakage conditions, were found. With increasing TOW thickness even higher values, up to 
13 kPa, occurred. One patient, previously fitted with a VP with a 10 mm shaftlength was 
unable to produce sound with the Nijdam VP. 
From our data we conclude that first of all the range of shaftlengths presently available is 
not sufficient to meet individual variations in TOW thickness. Secondly, the in vivo 
aerodynamic characteristics of the Nijdam VP differ essentially and unfavourably from in 
vitro data14. Possibly this is related to the fact that the oesophageal tissue, which plays a 
role in the barrier mechanism, has unfavourable characteristics in our patients due to 
previous irradiation and/or operation. 
Furthermore, although the trans-device pressure loss in several patients is within a low-
resistance range, the interindividual as well as the intraindividual variation is not 
acceptable. The risk of a significant increase in trans-device pressure loss with an 
unproperly sized shaftlength seems to be unavoidable in the absence of a measurement 
instrument for TOW thickness, especially in unexperienced hands. The absence of such a 
device might also lead to repeated replacements for testing the proper fit. 
The Nijdam VP has an innovative design" and a new barrier mechanism, but the in vivo 
aerodynamic characteristics of the Nijdam VP are of such nature that further 
investigations to adapt the design in order to lower the resistance of the Nijdam VP are 
obligatory. 
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ABSTRACT 
Prosthesis-assisted tracheo-oesophageal speech has proven its value in postlaryngectomy 
voice rehabilitation, although manual occlusion of the tracheostoma during speech is 
necessary. In contrast a tracheostoma valve enables hands-free speech. We have now had 
experience with 30 patients using the Blom-Singer tracheostoma valve for more than 6 
months and have found that most patients prefer prosthesis-assisted speech with the 
tracheostoma valve. Measurement of several speech parameters with digital and valve 
occlusion of the tracheostoma did not show any significant differences between the two 
speaking conditions. 
Problems included maintenance of an airtight seal, outward forcing of the valve dia-
phragm during forced expiration and subjective increased airflow resistance. 
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INTRODUCTION 
Since Blom and Singer3 introduced voice prosthesis assisted tracheo-oesophageal speech in 
1979, this method for post-laryngectomy voice rehabilitation has proven to be superior to 
oesophageal speech. At University Hospital Nijmegen speech rehabilitation was successful 
in 80% of our laryngectomized patients9. With the introduction of low-pressure voice 
prostheses6101314 and myotomy of the cricopharyngeal and lower pharyngeal constrictor 
muscle these results have even further improved912. However intermittent manual occlusi-
on of the tracheostoma is necessary to create a tracheo-oesophageal airflow during 
speech. This is a non-hygienic, inconvenient procedure for which some dexterity is 
needed. It, of course, ties hands and draws attention to the laryngectomized status. The 
stoma size in relation to the size of the fingertip is also of importance. 
In 1982 the tracheostoma valve for hands-free alaryngeal prosthetic speech was introdu-
ced by Blom et al.4. The device consists of a circular housing which is attached to the 
skin with non-irritating adhesive discs. The valve assembly, supporting the valve-
diaphragm, can be inserted and removed leaving the housing attached to the skin. In the 
first generation device the valve diaphragm was available in four thicknesses that defined 
the pressure needed to close the valve. The newly developed device has an adjustable 
valve. The valve sensitivity can be adjusted by rotating the face plate (Figure 1). It can 
also be provided with a heat and moisture exchanger (Figures 2, 3). 
Figure 1: By rotating the face plate of the tracheostoma valve the diaphragm can be 
partially closed to adjust the valve's sensitivity 
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Figure 2: The Blom-Singer adjustable tracheostoma valve with a foam filter. 
4
 Ші 
Figure 3: Lateral view of the adjustable tracheostoma valve in combination with the heat 
and moisture exchanger, which consists of a removable retaining cap and a 
replaceable foam filter. 
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Since the Blom-Singer valve has become more popular in The Netherlands, we assessed 
its value in the present study by evaluating the combined experience of University 
Hospital Nijmegen and the Daniel den Hoed Clinic, Rotterdam, the Netherlands. 
MATERIALS AND METHODS 
Thirty laryngectomized patients were selected between June 1992 and May 1993 and 
provided with a Blom-Singer tracheostoma valve. Selection criteria consisted of existing 
stoma-occlusion problems because of decreased manual dexterity (e.g arthritis) or stoma 
size and/or frequent bimanual activities in combination with speech. 
The patients included 24 men and 6 women, with an average age of 59 years (ranging 
from 40 - 73 yrs). Twenty-nine patients were using indwelling voice prostheses (low-
resistance Groningen voice prosthesis14, Provox voice prosthesis6, Nijdam voice 
prosthesis10). One of them had a well functioning Staffieri shunt. All were tracheo-
oesophageal speakers for 3 years on average (range 6 months to 11 years). 
The tracheostoma valve was used by the study group for an average period of 6 months, 
ranging from 3 to 14 months. One patient was excluded because excessive leakage of air 
underneath the valve housing and skin problems due to erythema, pruritis and a vesicular 
rash, limited his ability to participate. 
All Nijmegen patients were asked to return for evaluation of the tracheo-oesophageal 
voice with and without the tracheostoma valve. Recordings were made of 13 patients. All 
patients in Nijmegen and Rotterdam were also evaluated by questionnaire. 
RESULTS 
Manual tracheostoma occlusion was reported to be troublesome by half of the patients. If 
questioned about their speech rehabilitation approximately 60% said that oesophageal 
voice alone was unacceptable while 90% were satisfied with the results attained with the 
prosthesis-assisted tracheo-oesophageal speech. Combination of a valve with the prosthesis 
improved speech even further. Most patients (79%) preferred to speak with the prosthe-
sis, with or without using the valve. 
Some patients (31%) wore the tracheostoma valve all day but the majority chose specific 
activities such as visits (34%), work (17%) or leisure time activities (14%). 
93 
Chapter 7 
Tracheostoma valve application was found to be easy and required approximately 10 
minutes. Most patients did not need any assistance with placement. The valve stayed in 
place for an average period of 7 hours although there was a large interindividual variation 
(from 1 to 48 hrs). Removal with white spirit or alcohol was no problem. Skin problems 
were usually mild and mainly consisted of local erythema or pruritis and occurred in 24% 
of the patients. 
Maintenance of an airtight seal was one of the major problems found in patients and was 
associated with anatomy of the jugular fossa, the sternoclavicular joints and/or the sterno-
cleido-mastoid muscles. Excessive intratracheal pressure during speech and copious mucus 
discharge were other significant factors. Outward forcing of the diaphragm, mainly while 
coughing (93%) or with loud speech (38%), was a frequently mentioned problem. 
For 38% of the patients physical activity was impossible while wearing the tracheostoma 
valve because of increased airway resistance. Fifty percent experienced feelings of an 
obstructed airway. One third of the patients stated that usage of the valve during upper 
respiratory infections could be problematic. 
Table 1: Criteria used for evaluation of tracheo-oesophageal speech (adapted from 
Mahieu7) 
Parameter 
Availability 
Fluency 
Voice modulation 
Speech rate 
Speech quality 
Good 
Always immediately 
on request; voice 
onset delay < 5 s 
>L 19 
syllables per 
air intake 
Adequate 
pitch variation 
_>200 
syllables/min 
Maximum phonation time >_ 10 s 
Dynamic range >.25dB 
Moderate 
Occasionally voice onset 
delay > 5 s following 
request 
10-18 
syllables per 
air intake 
Little 
pitch variation 
150-200 
syllables/min 
4-9 s 
16-24 dB 
Poor 
Not available 
<.9 
syllables per 
air intake 
Monotonous 
<.150 
syllables/min 
<.3 s 
<. 15 dB 
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Some resolution was had with the recently introduced second generation tracheostoma 
valve containing an adjustable closing-pressure mechanism. This new device could also be 
combined with a heat and moisture exchanger to reduce mucus production2. 
Breathing noises and the click when the valve closes were usually not a problem for most 
of the patients although some found it annoying (17%). Seventy-eight percent said the 
effort to speak was increased with the valve. The quality of speech was believed to be 
different by 66%. Although there was no significant difference, 28% noticed a more 
relaxed voice and 21% a clearer voice. There was no apparent effect on the length of 
sentences or loudness of speech. 
Criteria used for evaluation of tracheoesophageal speech are shown in table l7. 
Of the 13 patients from the Nijmegen ENT Department who had recordings made of 
speech with and without tracheostoma valve, measurement of speech parameters with or 
without the valve did not show any significant differences (table 2). The tracheostoma 
valve was appreciated by most of the patients as a hands-free, less conspicuous, more 
hygienic and more comfortable way to speak in combination with various bimanual 
activities. One patient suffered from arthritis of his fingers and prosthetic speech became 
only possible with the use of the valve. Overall, 83% of the patients stated that they felt 
less handicapped with use of the tracheostoma valve. 
Table 2: Percentages of patients (n=13) judged to be good, moderate or poor tracheo-
oesophageal speakers for speech parameters under two different occlusion 
speaking conditions. 
Parameter 
Availability 
Fluency 
Voice modulation 
Speech rate 
Maximum phonation 
time 
Dynamic range 
Speech quality 
Good 
occlusion 
Valve 
92% 
92% 
77% 
85% 
54% 
31% 
Digital 
92% 
85% 
77% 
85% 
46% 
46% 
Moderate 
occlusion 
Valve 
8% 
-
8% 
8% 
31% 
46% 
Digital 
8% 
-
15% 
8% 
38% 
38% 
Poor 
occlusion 
Valve 
-
8% 
15% 
8% 
15% 
23% 
Digital 
-
15% 
8% 
8% 
15% 
15% 
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DISCUSSION 
Even though loss of voice can be a devastating side effect of total laryngectomy, a 
majority of patients are able to produce some degree of oesophageal voice. Since the 
introduction of the voice prosthesis, postlaryngectomy voice production has further 
improved rehabilitation options. However manual occlusion of the tracheostoma can be 
uncomfortable and unhygienic and attracts the eye to the laryngectomized status. Digital 
pressure on the tracheostoma soft tissue can also possibly increase resistance to airflow 
through the pharyngo-oesophageal (PE) segment. As hypertonicity at the PE-segment is a 
frequent cause of failure in acquiring oesophageal voice12 this can be considered as an 
undesirable side-effect. Use of the tracheostoma valve seems to solve some of the 
aformentioned problems. 
Evaluation of tracheo-oesophageal speech in our patients with and without the 
tracheostoma valve, according to the criteria shown in table 1, did not show any signifi-
cant differences for the speech parameters studied. This confirms the results found by 
Pauloski et al.". 
Unfavorable peristomal anatomy due to prominent sternocleidomastoid muscles or a deep 
tracheostoma can cause problems with placement of the tracheostoma valve. To overcome 
this problem, Barton et al1 modified the Helsper button to provide for attachment of a 
tracheostoma valve. Since the majority of patients do not need a stomal button, we 
currently do not think that the risk of stoma dilatation, granulation tissue formation or 
bleeding is worth the potential benefit. The customized valve housing described by Cantu 
et al.5 has got to prove its usefulness. 
We would stress from our experience that overproduction of mucus, excessive coughing 
or a high speaking pressure can be additional unfavourable conditions for use of a 
tracheostoma valve. These problems remain to be resolved in certain patients. Further 
development is required in the method of application of the valve, airway resistance and 
maintenance of an airtight seal. Outward forcing of the valve with loud speech is possibly 
resolved with introduction of the second generation Blom-Singer adjustable tracheostoma 
valve although coughing can still be a problem. By using a heat and moisture exchanger 
with the adjustable valve, airway irritation and mucus production can also be reduced 
significantly. 
Despite the limitations cited in our study, our findings show that the tracheostoma valve is 
indeed a valuable addition in voice rehabilitation of the laryngectomized patient. 
96 
The Blom-Singer tracheostoma valve 
ACKNOWLEDGEMENT 
The authors wish to thank Mr Eric Blom for reviewing the manuscript and making helpful 
comments. 
REFERENCES 
1. Barton D, DeSanto L, Pearson BW, Keith R. An endostomal tracheostomy tube for 
leakproof retention of the Blom-Singer stomal valve. Arch Otolaryngol Head Neck 
Surg 1988; 99: 38-41. 
2. Blom ED. Laboratory and clinical investigation of postlaryngectomy airway 
humidification and filtration. Book of abstracts, 1st EGFL conference and 5th 
International Congress on Surgical and Prosthetic Voice Restoration After Total 
Laryngectomy. 1993; 10-12 September, Grado, Italy. 
3. Blom ED, Singer MI. Surgical-prosthetic approaches for postlaryngectomy voice 
restoration. In: Keith RL, Darley FL (eds) Laryngectomee rehabilitation. College 
Hill Press, Houston, 1979; pp 251-276. 
4. Blom ED, Singer MI, Hamaker RC. Tracheostoma valve for postlaryngectomy voice 
rehabilitation. Ann Otol Rhinol Laryngol 1982; 91: 576-578. 
5. Cantu E, Shagets FW, Fifer RC, Andres CJ, Newton AD. Customized valve 
housing. Laryngoscope 1986; 96: 1159-1163. 
6. Hilgers FJM, Schouwenburg PF. A new low-resistance, self-retaining prosthesis 
(Provox) for voice rehabilitation after total laryngectomy. Laryngoscope 1990; 100: 
1202-1207. 
7. Mahieu HF. Voice and speech rehabilitation following laryngectomy. PhD thesis, 
Groningen University, The Netherlands, 1988. 
8. Mahieu HF, Annyas AA, Schutte HK, van der Jagt EJ. Pharyngo-oesophageal 
myotomy for vocal rehabilitation of laryngectomees. Laryngoscope 1987; 97: 451-
457. 
9. Manni JJ, van den Broek P. Surgical and prosthesis-related complications using the 
Groningen button voice prosthesis. Clin Otolaryngol 1990; 15: 515-523. 
10. Nijdam HF, Marmi JJ, Nicolasen M. A new valveless low-pressure voice prosthesis. 
Clin Otolaryngol 1990; 15: 561. 
11. Pauloski BR, Fisher HB, Kempster GB, Blom ED. Statistical differentiation of 
tracheooesophageal speech produced under four prosthetic/occlusion speaking 
conditions. J Speech Hear Res 1989; 32: 591-599. 
12. Singer MI, Blom ED. Selective myotomy for voice restoration after total 
laryngectomy. Arch Otolaryngol Head Neck Surg 1981; 107: 670-673. 
13. Smith BE. Aerodynamic characteristics of Blom-Singer low-pressure voice 
prostheses. Arch Otolaryngol Head Neck Surg 1986; 112: 50-52. 
14. Zijlstra RJ, Mahieu HF, van Lith-Bijl JT, Schutte HK. Aerodynamic properties of 
the low-resistance Groningen button. Arch Otolaryngol Head Neck Surg 1991; 117: 
657-661. 
97 

Chapter 
8 
Summary and Conclusions 

Summary and conclusions 
SUMMARY AND CONCLUSIONS 
Loss of the vocal cords after total laryngectomy (surgical resection of the voice box), 
chiefly as the result of cancer of the throat, is one of the great disadvantages associated 
with this operation. Over the past 15 years, speech rehabilitation with the aid of voice 
prostheses has greatly improved the possibility of verbal communication compared to the 
previous methods: injection oesophageal speech or communication with the electrolarynx. 
This has resulted in the development of various voice prostheses, three of which in the 
Netherlands. This thesis describes the Nijdam voice prosthesis and the results achieved 
with it at the Ear, Nose and Throat Department of the University Hospital Nijmegen, the 
Netherlands. In addition, the results are presented of a prospective clinical study in which 
the Groningen, Nijdam and Provox voice prostheses were compared. 
The necessity of closing the tracheostoma with a finger during communication with a 
voice prosthesis is experienced as a disadvantage. Tracheostoma valves are being 
developed that enable the laryngectomy patient to close the tracheostoma without using 
his/her hands. Practicalities and limitations of 'hands-off speech with the current 
generation of tracheostoma valves are discussed. 
Chapter 1 presents a historical overview in which total laryngectomy is discussed in the 
light of the development of laryngology and surgical (prosthetic) speech rehabilitation. 
One of the major problems with the use of voice prostheses is that the silicone from 
which they are made, is very susceptible to damage from fungal growth. This fungal 
growth changes the quality and characteristics of the silicone material thus limiting the 
life-span and function of a voice prosthesis. The valve mechanism is particularly 
vulnerable to fungal growth. This valve mechanism prevents the leakage of food and 
mucous from the oesophagus into the trachea. In an attempt to decrease the negative 
effect of fungal growth, a new voice prosthesis has been developed with a barrier 
mechanism that consists of a biological part and a prosthetic part. This Nijdam voice 
prosthesis is described in Chapter 2. The device lifetime of this prosthesis proved to be 
significantly longer than that of the Groningen or Provox voice prosthesis. In addition, 
the shape and flexibility of the Nijdam voice prosthesis facilitates the replacement 
procedure. 
In Chapter 3 the clinical results with the Groningen, Nijdam and Provox voice prostheses 
are described, based on 845 replacement procedures carried out on 158 patients. The 
Nijdam voice prosthesis with an average device lifetime of 19 weeks proved to function 
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significantly longer than the Groningen or Provox voice prosthesis, with lifetimes of 15.8 
and 13 weeks on average, respectively. Leakage formed the most important reason to 
replace the prosthesis: in 58.8% of the Groningen prosthesis users, 55% of the Nijdam 
users and 80.2% of the Provox users. These percentages are significantly different. The 
necessity to replace the Provox voice prosthesis owing to increased airflow resistance 
during speech (22.7%) occurred significantly less frequently than with the Groningen 
(45.4%) and Nijdam (45.9%) voice prostheses. Local complications were more frequent 
with the Nijdam voice prosthesis. Replacement under general anaesthetic took place only 
incidentally: in 3% of the replacements. 
The rate of progress and the end results of speech rehabilitation after total laryngectomy 
with the Groningen, Nijdam and Provox voice prostheses were evaluated in a prospective 
study which forms the basis of Chapter 4. At set times, various parameters were 
evaluated: utterance size, phonation time, dynamic range, speech rate, availability, 
fluency and intelligibility of speech, voice quality and stoma technique. Particularly the 
speech rate and the stoma technique appear to improve significantly over time. Fluency, 
intelligibility of speech and the total result also show positive tendencies over time. No 
significant differences were found in the above-mentioned parameters between the 
Groningen, Nijdam and Provox voice prostheses. 
Over the past few years, the importance of the airflow resistance of a voice prosthesis and 
its possible effect on speech acquisition has become increasingly apparent. This has meant 
that since their introduction, the majority of voice prostheses have undergone 
modifications in order to reduce the airflow resistance. Until recently, the aerodynamic 
characteristics of the Nijdam voice prosthesis were unknown. Owing to the inovative 
design of this valveless prosthesis, it was necessary to develop a special in vitro model to 
evaluate its characteristics. Chapter 5 provides details. With the aid of this in vitro 
model, the aerodynamic characteristics of the Nijdam prosthesis were determined. The 
airflow resistance proved to be comparable with the in vitro values of other low-resistance 
voice prostheses. 
The properties of the oesophageal mucosa were found to be of importance for the 
functioning of the closure mechanism of the Nijdam voice prosthesis. In laryngectomy 
patients, the oesophageal mucosa might be affected by the surgical intervention and/or 
adjuvant radiotherapy. Therefore, during the course of the study, it was considered 
necessary to examine the aerodynamic characteristics of the Nijdam voice prosthesis in 
vivo. Chapter 6 describes the results of the in vivo study. The aerodynamic values 
measured in vivo appeared to be less favourable than those measured in vitro. It is 
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therefore necessary to modify the Nijdam vocie prosthesis to improve its airflow 
resistance. 
The generation of speech by means of oesophageal speech, whether or not assisted by a 
voice prosthesis, is only possible if the passing airflow causes vibration of the mucosa of 
the oesophagus and hypopharynx. When a voice prosthesis is used, the air flows from the 
trachea into the oesophagus passing the prosthesis positioned between them. During 
expiration, it is necessary to close off the tracheostoma with a finger. This makes it 
impossible to perform bimanual activities while speaking. To achieve hands-off speech, 
tracheostoma valves have been developed that close the tracheostoma automatically during 
expiration. The tracheostoma valve needs to be glued to the surrounding skin before it can 
be used. The modern versions can be combined with a so-called artificial nose that cleans, 
warms and moistens the air breathed in via the stoma. Thirty patients were fitted with an 
automatic tracheostoma valve. Their experience with this device, which is fairly new in 
the Netherlands, is described in Chapter 7. Although the majority of patients preferred to 
use a voice prosthesis in combination with a tracheostoma valve, various practical 
problems impeded the unconditional success of the automatic device. For instance, the 
membrane that closes the trachea during speech showed a tendency to be forced outwards 
if the user coughed or spoke loudly. In addition, the subjective experience of increased 
airway resistance and the fact that the ring became unstuck from the skin are aspects that 
require improvement. The speech variables measured while using the automatic 
tracheostoma valve did not differ from those measured while using the digital 
tracheostoma closure technique. 
Voice-prosthesis-assisted oesophageal speech after total laryngectomy is a field that is still 
undergoing development. The existing voice prostheses can certainly be improved further. 
If fungal-growth-resistant (silicone) material can be manufactured, it would be a major 
step forward. Attempts are being made to simplify the replacement procedure into, for 
instance, a transtracheal method. Solutions need to be found for the practical problems 
associated with the use of tracheostoma valves. Using an artificial nose in combination 
with a tracheostoma valve looks very promising. 
Besides the above-mentioned developments, continuous efforts are being made to find new 
techniques and to formulate indications for larynx-sparing surgery with maintenance of 
the normal swallowing action and without a permanent tracheostomy. Surgical 
intervention nearly always affects voice quality, with the possible exception of 
stroboscopically-guided laser surgery for the treatment of small laryngeal tumours. In the 
near future, new developments in larynx-sparing techniques might mean that an increasing 
number of patients do not have to undergo total laryngectomy. 
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SAMENVATTING EN CONCLUSIES 
Het verlies van de stembanden na totale laryngectomie (verwijdering van het strottehoofd) 
is één van de grote nadelen die aan deze, meestal ten gevolge van keelkanker noodzakelij-
ke operatie verbonden zijn. De spraakrevalidatie na totale laryngectomie met behulp van 
spraakprothesen heeft de laatste 15 jaar de mogelijkheden van verbale communicatie 
enorm verbeterd ten opzichte van de tot dan gangbare methoden: de injectie slokdarm-
spraak of communicatie met de electrolarynx. Dit heeft geresulteerd in de ontwikkeling 
van diverse spraakprothesen waarvan een drietal in Nederland. 
Dit proefschrift beschrijft de Nijdam spraakprothese en de resultaten die daarmee op de 
afdeling Keel- Neus- Oorheelkunde van het Sint Radboudziekenhuis te Nijmegen geboekt 
zijn. 
Daarnaast worden de resultaten beschreven van een prospectieve klinische studie waarin 
de Groningen, Nijdam en Provox spraakprothesen met elkaar worden vergeleken. 
De noodzaak tot het met de hand afsluiten van het tracheostoma (luchtpijpstoma) tijdens 
communicatie met behulp van een spraakprothese wordt als een nadeel ervaren. Tracheo-
stomakleppen vormen een nog steeds in ontwikkeling zijnde voorziening welke het 
gelaryngectomeerden mogelijk moet maken het tracheostoma handvrij af te sluiten. De 
mogelijkheden en beperkingen van handvrij spreken met behulp van de huidige generatie 
tracheostomakleppen komen aan de orde. 
In Hoofdstuk 1 wordt een historisch overzicht gegeven waarin de totale laryngectomie, 
binnen de opkomst van de laryngology (keelheelkunde), en de chirurgische (prothetische) 
spraakrevalidatie nader worden toegelicht. 
Eén van de grote problemen bij het gebruik van spraakprothesen is de gevoeligheid van 
het siliconen materiaal, waaruit de prothese gemaakt is, voor schimmelingroei. Deze 
schimmelingroei verandert de kwaliteit en de eigenschappen van het siliconen materiaal. 
Dit beperkt de levensduur en het functioneren van een spraakprothese en met name het in 
de prothese aanwezige klepmechanisme. Dit klepmechanisme voorkomt lekkage van 
voeding en slijm vanuit de slokdarm naar de luchtpijp. In een poging het negatieve effect 
van schimmelaantasting te verminderen werd een nieuwe spraakprothese ontwikkeld met 
een barrière mechanisme bestaande uit een biologisch en een prothetisch gedeelte. Deze 
zogenaamde Nijdam spraakprothese wordt in hoofdstuk 2 beschreven. De levensduur van 
deze prothese bleek significant langer te zijn dan die van de Groningen en Provox spraak-
prothese. Daarnaast bleek de vorm en flexibiliteit van de prothese bij te dragen aan de 
eenvoud van de procedure ter vervanging van de spraakprothese. 
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In hoofdstuk 3 worden de klinische resultaten met de Groningen, Nijdam en Provox 
spraakprothesen beschreven gebaseerd op 845 prothesewisselingen uitgevoerd bij 158 
patiënten. De Nijdam spraakprothese bleek met een levensduur van 19 weken significant 
langer te functioneren dan de Groningen en Provox spraakprothesen welke bij respectieve-
lijk 15.8 en 13 weken aan vervanging toe waren. Lekkage bleek de belangrijkste reden 
om de prothese te vervangen en kwam voor bij 58.8% van de Groningen, 55% van de 
Nijdam en 80.2% van de Provox spraakprothese gebruikers. Deze percentages zijn 
onderling significant verschillend. De noodzaak de Provox spraakprothese te wisselen 
vanwege verhoogde druk tijdens spraak (22.7%) kwam significant minder frequent voor 
dan bij de Groningen (45.4%) en Nijdam (45.9%) spraakprothesen. Lokale complicaties 
kwamen vaker voor bij de Nijdam spraakprothese. Wisselingen onder narcose waren bij 
alle drie de spraakprothesen slechts incidenteel noodzakelijk, totaal in 3% van de 
wisselingen. 
De mate van voortgang en het eindresultaat van de spraakrevalidatie na totale laryngecto-
mie met de Groningen, Nijdam en Provox spraakprothesen werden in een prospectieve 
studie onderzocht en vormen de basis voor Hoofdstuk 4. Omvang van een uiting, fonatie 
duur, dynamiek, spreektempo, beschikbaarheid, vloeiendheid, verstaanbaarheid en 
kwaliteit van de stem alsmede de stomatechniek werden daartoe op gezette tijden 
beoordeeld. Vooral spreektempo en stomatechniek bleken in de tijd significant te 
verbeteren. Vloeiendheid en verstaanbaarheid van de stem en het totale resultaat toonden 
een positieve tendens in de tijd. Er werden voor de bovengenoemde parameters geen 
significante verschillen gevonden tussen de Groningen, Nijdam en Provox 
spraakprothesen. 
Het belang van de luchtweerstand van een spraakprothese en het mogelijk effect daarvan 
op de spraakverwerving is de laatste jaren steeds meer in de belangstelling gekomen. Dit 
heeft er onder andere toe geleid dat de meeste spraakprothesen sinds hun introductie 
modificaties hebben ondergaan teneinde de invloed van de luchtweerstand te verminderen. 
De aërodynamische karakteristieken van de Nijdam spraakprothese waren tot op heden 
onbekend. Gezien het bijzondere ontwerp van deze kleploze prothese moest er een 
speciaal in vitro model ontworpen worden om deze karakteristieken te bepalen. In 
hoofdstuk 5 wordt hier nader op in gegaan. Met behulp van dit in vitro model werden de 
aërodynamische eigenschappen van de Nijdam spraakprothese bepaald. De luchtweerstand 
bleek in vitro vergelijkbaar met de in vitro waarden van andere lage druk prothesen. 
De eigenschappen van het slokdarmslijmvlies blijken van belang te zijn voor het 
functioneren van het afsluitmechanisme van de Nijdam spraakprothese. Het 
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slokdarmslijmvlies van gelaryngectomeerde patiënten is mogelijk nadelig beïnvloed door 
de ondergane chirurgische en eventueel radiotherapeutische behandeling. Daarom werd in 
de loop van het onderzoek een studie noodzakelijk geacht ter bepaling van de in vivo 
aërodynamische eigenschappen van de Nijdam spraakprothese. In hoofdstuk 6 worden de 
resultaten beschreven van de in vivo studie. De in vivo gemeten aërodynamische 
eigenschappen blijken ongunstiger te zijn dan de in vitro gevonden waarden. Het is 
daarom noodzakelijk de Nijdam spraakprothese te modificeren ter verbetering van zijn 
luchtweerstand. 
Het genereren van spraak bij, al dan niet spraakprothese ondersteunde, slokdarmspraak is 
slechts mogelijk wanneer de passerende luchtstroom het slokdarm- en hypopharynx-
slijmvlies in trilling brengt. Deze luchtstroom loopt bij gebruik van een spraakprothese 
van de luchtpijp naar de slokdarm via de daartussen geplaatste prothese. Tijdens 
uitademing dient daartoe wel het tracheostoma met een vinger te worden afgesloten. Dit 
maakt bimanuele activiteiten in combinatie met spraak onmogelijk. Ten einde handvrije 
spraak mogelijk te maken zijn tracheostomakleppen ontwikkeld welke het tracheostoma 
tijdens uitademing automatisch afsluiten. Tracheostoma kleppen moeten voor gebruik met 
behulp van lijm op de huid rondom het tracheostoma worden geplakt. De moderne versies 
kunnen gecombineerd worden met een zogenaamde "kunstneus" welke de via het stoma 
ingeademde lucht reinigen, verwarmen en bevochtigen. Dertig patiënten werden met een 
tracheostomaklep uitgerust. Hun ervaring met deze in Nederland redelijk nieuwe 
voorziening zijn weergegeven in hoofdstuk 7. Hoewel de meeste patiënten de voorkeur 
gaven aan het gebruik van een spraakprothese in combinatie met een tracheostomaklep 
staan praktische problemen een onvoorwaardelijk succes in de weg. Met name kan de 
membraan die bij spraak de luchtpijp afsluit, doorslaan bij hoesten of luide spraak. De 
subjectief verhoogde luchtweerstand en het loslaten van de op de huid gelijmde ring zijn 
aspecten die om verbetering vragen. De gemeten spraakvariabelen bij gebruik van de 
tracheostomaklep bleken niet te verschillen van die gemeten bij digitale tracheostoma 
afsluiting. 
De spraakprothese ondersteunde slokdarmspraak na totale laryngectomee is een gebied dat 
nog steeds in ontwikkeling is. De bestaande spraakprothesen kunnen zeker nog verbeterd 
worden. De ontwikkeling van schimmelresistent (siliconen)materiaal zou een belangrijke 
vooruitgang betekenen. Vereenvoudiging van wisselprocedures tot bijvoorbeeld 
transtracheale verwisselingen is in ontwikkeling. De praktische problemen verbonden aan 
het gebruik van tracheostomakleppen vragen om een oplossing. De combinatie hiervan 
met kunstneuzen is veelbelovend. 
Separaat aan deze ontwikkeling worden voortdurend nieuwe technieken ontwikkeld en 
indicaties geformuleerd voor larynxsparende chirurgie met behoud van normale slikact en 
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zonder permanent tracheostoma. Vaak gaat dit echter ten koste van stemkwaliteit, met 
uitzondering van wellicht de stroboscopisch gecontroleerde laserchirurgische behandeling 
van kleinere larynxtumoren. Door deze ontwikkelingen zal een in de nabije toekomst 
toenemend aantal patiënten een laryngectomie bespaard kunnen blijven. 
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F.J. A van den Hoogen 
1 De beste spraakprothese bestaat niet. Er zijn wel goede alternatieven. 
2 De mate van voortgang en het eindresultaat van de spraakrevalidatie na totale 
laryngectomie hangen niet af van het feit of een Groningen, Nijdam of Provox 
spraakprothese wordt geplaatst. 
3 De variabele en onvoorspelbare luchtweerstand van de Nijdam spraakprothese 
maakt deze in zijn huidige vormgeving minder geschikt voor initiële plaatsing dan 
de Groningen of Provox spraakprothese. 
4 In vitro bepaalde aërodynamische eigenschappen van spraakprothesen wijken af 
van die in vivo. 
5 De tracheostomaklep komt bij geselecteerde patiënten tegemoet aan de wens tot 
handvrij spreken. 
6 Indien een spraakprothese niet wordt gebruikt dient de spraakprothese te worden 
verwijderd ondanks de frequent voorkomende noodzaak de fistel chirurgisch te 
sluiten. 
7 Bij afwezige of slechte prothese ondersteunde tracheo-oesophageale spraak dient 
men, door te laten spreken zonder prothese, een prothese gerelateerd probleem uit 
te sluiten alvorens over te gaan tot cinematografisch onderzoek van de slokdarm. 
8 Eén van de belangrijkste voorwaarden voor een succesvolle spraakprothese 
ondersteunde spraakrevalidatie na laryngectomie is de betrokkenheid van de 
behandelend arts en logopediste. 
9 De beoordeling van prevertebrale spierinvasie door pharynxachterwand carcinomen 
op CT-scan is onbetrouwbaar. F.J.A. van den Hoogen et al. Am J Surg (1996). 
10 In een welvaartsmaatschappij waarin de overheid ongelimiteerd verdient aan de 
tabaksindustrie zou de hoofd-hals oncologische zorg ongebutgetteerd dienen te 
zijn. 
11 Harmonisatie van tarieven en de daaraan gekoppelde compensatie voor academisch 
werkzame specialisten zijn weloverwogen stappen richting een volledig dienstver-
band. 
12 Het feit dat men aan de KUN in het nieuwe curriculum Geneeskunde niet meer 
spreekt van collegebanken maar van een "studielandschap" biedt studenten wellicht 
de mogelijkheid een aanvullende studiebeurs te verkrijgen via het ministerie van 
Milieu en Ruimtelijke Ordening of de afdeling groenvoorziening van de gemeente 
Nijmegen. 
13 Een allochtone oranje supporter geeft blijk van een succesvolle integratie in onze 
samenleving. 



